Participants list

Industries
Abbott Bioresearch Center, USA
Abbott Laboratories, USA
ActivX Biosciences, USA
ADV Bioscience LLC, USA
AstraZeneca, UK
Biogen Idec, Inc., USA
BioPerspectives, USA
Boehringer Ingelheim Pharma GmbH, Germany
Boryung Pharmaceutical Company, Korea
Bruker daltonik GmbH, Germany
Cangen Biotechnologies, USA
Cellzome AG, USA
Centocor R&D Inc., USA
CSIRO Molecular & Health Technologies, Australia
DSM Biologics Company BV, The Netherlands
Eprogen, Inc., USA
Eureka Therapeutics Inc., USA
F. Hoffmann-La Roche, Switzerland
Fluorotronics, Inc., USA
FOGALE Nanotech, France
GE Global Research Center, USA
Genetix, UK.
GenScript Corporation, USA
Genzyme, Switzerland
Hoffmann-LaRoche Inc., USA
HTL Biosolutions Inc., USA.
JENEIL BioProducts GmbH, Germany
Kyorin Pharmaceutical Co., LTD., USA
Lectus Therapeutics Ltd, UK
Life Technologies, USA
Medarex Inc., USA
Medicinal Chemistry, UCB, UK
MedImmune LLC, USA
Merck & Co., Inc., USA
Millipore Corporation, USA
Nerviano Medical Sciences, Italy
NeuroDrug Consulting, USA
Novartis, China
Novozymes A/S, Denmark
PamGene BV, The Netherlands
Pfizer Global Research and Development, USA
Pharmadiscover Inc., China
Prolexys Pharmaceuticals, USA
Rainbow Bioscience, LLC, USA
Sanofi Pasteur, France
Seattle Genetics, USA
Sigma-Aldrich Biotechnology, USA
Sundia MediTech Company, Ltd., China
SuppreMol GmbH, Germany
Trellis Bioscience, USA
Vitae Pharmaceuticals Inc., USA
Vybion,Inc., USA
Wyeth Research, USA

Academia

Advanced Science Institute, Japan
Agricultural Research Council( CRA ), Italy
AIIMS, India
AIST Tokyo Waterfront, Japan
Biotechnology Research Institute, Canada
Boston University School of Medicine, USA
Brussels Center for Redox Biology, Belgium
Butler University, USA
Cardiff University, UK
Case Western Reserve University School of Medicine, USA
Cell Surface Signalling Laboratory, UK
Centinela Freeman Memorial Hospital, USA
Central Division of Analytical Chemistry, Germany
Chemistry RAMS, Russia
Children's Hospital of Orange County, USA
Clinical Proteomics Center, Taiwan
Consortium for Genomic Technologies, Italy
Cornell University, USA
Craig Venter Institute, USA
Dalhousie University, Canada
Department of Chemistry, University of Ioannina, Greece
Eindhoven University of Technology, The Netherlands
Erasmus Medical Center, Netherlands
ETH Zurich, Switzerland
Federal University of Rio de Janeiro, Brazil
Florida State University, USA
Fox Chase Cancer Center, USA
Fred Hutchinson Cancer Research Center, USA
Georgia Institute of Technology, USA
Goethe University, Germany
Hannam University, Korea
Harvard University, USA
HELIOS Klinikum Berlin-Buch and Experimental and Clinical Research Center, Germany
Hiroshima University, Japan
Hungarian Academy of Sciences, Hungary
Ibaraki University, Japan
Idaho State University, USA
Indiana University, USA
Institut de Pharmacologie Moléculaire et Cellulaire, France
Institut Pasteur de Lille, France
Institute for Biology and Chemistry of Proteins, France
Institute of Mechanics Bulgarian Academy of Sciences, Bulgaria
Institute of Microbial Technology, India
Institute of Molecular Biology and Biological Physics, USA
Iwate medical University, Japan
Jamia Millia Islamia(Central University), India
Johns Hopkins Hospital, USA
Johns Hopkins University School of Medicine, USA
Joseph Fourrier University, France
Karolinska University Hospital, Sweden
Katholieke Universiteit, Belgium
King Saud University, Kingdom of Saudi Arabia
Kyoto University, Japan
Kyungpook National University, Korea
Liver Research Center & Department of Hepato-Gastroenterology, Taiwan
London Research Institute, UK
M. D. Anderson Cancer Center, USA
Masaryk University, Czech Republic
Max-Planck Institute of Molecular Physiology, Germany
McGill University, Canada
McMaster University, Canada
Middle East Technical University, Turkey
Midwestern University, USA
MIT, USA
Moffitt Cancer Center & Research Institute, USA
Monash University, Australia
Mount Sinai School of Medicine, USA
Nara Institute of Science and Technology, Japan
Nara Women's University, Japan
National Institutes of Health, USA
National University of Singapore, Singapore
Newcastle University, UK
Northwest A & F University, China
Osaka University, Japan
oungnam University, Korea
Padmashree Dr. D.Y. Patil University, India
Princeton University, USA
Proteomics International, Australia
PSG College of Pharmacy, India
Rensselaer Polyechnic Institute, USA
Rice University, USA
Second Affiliated Hospital of Soochow University, China
Sejong University, Korea
Seoul National University, Korea
St. Jude Children's Research Hospital, USA
Stanford University, USA
State University of New York, USA
Stony Brook University, USA
Stowers Institute for Medical Research, USA
The Chinese University of Hong Kong, China
The Hebrew University of Jerusalem, Israel
The Italian Institute of Technology, Italy
The Ohio State University, USA
The University of Adelaide, Australia
The University of Iowa, USA
The University of Kansas, USA
The University of Melbourne, Australia
The University of North Carolina at Chapel Hill, USA
The University of Tokyo, Japan
The University of Texas M.D. Anderson Cancer Center, USA
Tohoku University, Japan
United States Department of Agriculture, USA
Universidad Nacional Autnoma de Mxico, Mexico City
Universita degli studi di pavia, Italy
Université de Montréal, Canada
Universite de Sherbrooke, Canada
Université Paris, France
Université Rennes, France
University College London, UK
University Graz, Austria
University in Innsbruck, Austria
University of Bristol, UK
University of California, USA
University of Chicago, USA
University of Chicago, USA
University of Cincinnati, USA
University of Erlangen-Nuremberg, Germany
University of Florida College of Medicine, USA
University of Haifa, Israel
University of Heidelberg, Germany
University of Hong Kong, China
University of Illinois, USA
University of Ioannina, Greece
University of Leeds, UK
University of Leeds, UK
University of Liverpool Cancer Research Centre, UK
University of Malaya centre for Proteomics research, Malaysia
University of Medical Sciences, Iran
University of Melbourne, Australia
University of Michigan, USA
University of Minnesota, USA
University of Mississippi Medical Center, USA
University of Miyazaki, Japan
University of Montreal, Canada
University of Munich, Germany
University of North Carolina at Chapel Hill, USA
University of North Carolina, USA
University of Oslo, Norway
University of Otago, Christchurch Cardioendocrine Research Group, New Zealand
University of Oulu, Finland
University of Oulu, Finland
University of Pennsylvania, USA
University of Pittsburgh Drug Discovery Institute, USA
University of Pittsburgh School of Medicine, USA
University of Pittsburgh, USA
University of Portsmouth, UK
University of Rochester School of Medicine and Dentistry, USA
University of Science and Technology of Lille, France
University of South Australia, Australia
University of Stuttgart, Germany
University of Tartu, Estonia
University of Texas Medical Branch, USA
University of Texas, USA
University of Tokyo, Japan
University of Toronto, Canada
University of Virginia, USA
University of Washington, USA
University of Waterloo, Canada
University of Western Ontario, Canada
University of Western Sydney, Australia
University of Zagreb, Croatia
University of Zürich, Switzerland
University of California, USA
University of Houston, USA
University of Illinois College of Medicine, USA
University of Massachusetts Medical School, USA
University of Pittsburgh School of Medicine, USA
Uppsala University, Sweden
Vanderbilt University Medical Center, USA
Vanderbilt University, USA
Walter and Eliza Hall Institute of Medical Research, Australia
Weill Medical College of Cornell University, USA
Yale University School of Medicine, USA
Yale University, USA
Yokohama National University, Japan
Yonsei University, Korea
Youngnam University, Korea


Scientific Program

BIT Life Sciences' 3 rd Annual PepCon-2010

Theme: After a Solution for the Machines of Life

Time: March 21-23, 2010 Venue: Beijing International Convention Center, Beijing, China

-----------------------------------------------------------------------------------------------------------------------------

Scientific Program

Experts from both academia and industries are invited to present contemporary information from current research through commercial implementation of new technologies. Time allotted for oral presentations will be 25 to 40 minutes. English is the conference language. You can submit your abstracts by: Abstract Submission

Time

Activities

March 21, 2010
08:00-11:50

Opening Ceremony
Moderator
Dr. Jianguo Yang, Principal Scientist and Group Leader, Genzyme, USA

08:00-08:30

Group Photo

09:00-09:05

Chair' s Opening Remark

09:05-09:35

  • Executives of GO and NGO of Protein Science Organizations
  • Governmental Regulatory Officers
  • Leading Scientists
  • Industrial Leaders in Therapeutic Protein Development
  • Keynote Forum
    09:40-10:05

    Title: Advances in Proteomic Profiling of Cancers: Alternative Splice Variants as a New Class of Biomarker Candidate
    Dr. Gilbert Omenn, Professor, University of Michigan, Leader of Human Plasma Proteome Project (HPPP), USA

    10:05-10:30

    Title: Structurally Disordered Proteins: Roles in Development
    Dr. A. Keith Dunker, T-K Li Professor of Medical Research, Indiana University, Founder/Father of The Protein Trinity, USA

    10:30-10:55
    Title: The Unfolded Protein Response: Cellular Response That Maintains the Homeostasis of the Endoplasmic Reticulum
    Dr. Kazutoshi Mori, Professor, Department of Biophysics, Graduate School of Science, Kyoto University, Japan
    10:55-11:20
    Title: Molecular Machines Mediating Translocation of Proteins across and into the Membranes of Mitochondria
    Dr. Walter Neupert,
    Chairman of the EMBO Council, Professor , University of Munich, Germany
    11:20-11:45
    Sponsor Speech
    Ms. Catherine TARRADE,
    New Products Marketing Coordinator, Abcam plc, UK

    March 21, 2010
    12:00-13:00

    Luncheon

    March 21, 2010
    18:00-20:00

    Welcome Banquet
    Symposium 1: Basic Protein Science
    Session 1-1: Advances of Protein Molecular Biology and Cell Biology
    Time: March 21, 2010 13:30- 17:30

    Session Chair

    Dr. Todd R. Graham, Director of Graduate Studies, Department of Biological Sciences, Vanderbilt University, USA

    Co-Chair

    Dr. Walter Neupert, Chairman of the EMBO Council, Professor, University of Munich, Germany

    13:30-13:55

    Title: Light-activated DNA Binding in a Designed Allosteric Protein
    Dr. Tobin Roy Sosnick, Director, Institute for Biophysical Dynamics, Department of Biochemistry & Molecular Biology, University of Chicago, USA

    13:55-14:20

    Title: Tail-anchored Membrane Protein Biogenesis
    Dr. Robert Keenan, Assistant Professor, Dept. of Biochemistry & Molecular Biology, University of Chicago, USA 

    14:20-14:45

    Title: Phospholipid Flippases and Their Influence on Membrane Biogenesis and Vesicular Transport
    Dr. Todd R. Graham,
    Director of Graduate Studies, Department of Biological Sciences, Vanderbilt University, USA

    14:45-15:10

    Title: Spatial and Temporal Organization of the E. coli PTS Proteins
    Dr. Orna Amster-Choder, Professor, Department of Molecular Biology, The Hebrew University Medical School, Israel

    15:10-15:30

    Coffee Break

    15:30-15:55

    Title: Uncovering the Molecular Mechanism of High Affinity Interaction between V-ATPase and Small GTPases
    Dr.
    Vladimir Marshansky, Assistant Professor of Medicine, Department of Medicine, Harvard Medical School, USA

    15:55-16:20

    Title: Functional Analysis of Lysosomal Peptide Transporters in C. elegans
    Dr. Takahiro Tanji , Assistant Professor, Department of Immunobiology , School of Pharmacy, Iwate medical University, Japan

    16:20-17:30

    Panel Discussion

    Session 1-2: Protein Folding Dynamics, Stability and Quality Control
    Time: March 21, 2010 13:30- 17:30

    Session Chair

    Dr. Kunihiro Kuwajima, Professor, Okazaki Institute for Integrative Bioscience, National Institutes of Natural Sciences, Japan

    Co-Chair

    Dr. Thomas Weikl, Group Leader, Department of Theory and Bio-Systems, Max Planck Institute of Colloids and Interfaces, Germany

    13:30-13:55

    Title: Conformational Changes during Protein Folding and Binding Revealed by Mutational Analysis
    Dr. Thomas Weikl, Group Leader, Department of Theory and Bio-Systems, Max Planck Institute of Colloids and Interfaces, Germany

    13:55-14:20

    Title: FAST Prediction of Protein Thermodynamics
    Dr. Donald J. Jacobs, Associate Professor of Physics, University of North Carolina at Charlotte, USA

    14:20-14:45

    Title: Architectural Role of Idiosyncratic Helix-turn-helix Motif in Methanogenic-type Seryl-tRNA-synthetase
    Dr.
    Ivana Weygand-Durasevic, Professor of Biochemistry, University of Zagreb, Croatia

    14:45-15:10

    Title: Identification and Stabilization of an Excited State in the Molecular Switch Ras in Order to Modulate Enzyme Activity
    Dr. Michael Spoerner, Project Leader, University of Regensburg, Germany

    15:10-15:30

    Coffee Break

    15:30-15:55

    Title: Is the Folding Pathway Conserved in Homologous Proteins?
    Dr. Kunihiro Kuwajima, Professor, Okazaki Institute for Integrative Bioscience, National Institutes of Natural Sciences, Japan

    15:55-16:20

    Title: Stability and Folding of Hyperthermophilic Proteins
    Dr.
    Kazufumi Takano, Associate Professor, Department of Material and Life Science, Osaka University, Japan

    16:20-16:45

    Title: Single Molecule Study Proves Barrier-Limited Folding Mechanism of PDBA and BBL
    Dr. Fang Huang, Professor, Center for Bioengineering and Biotechnology, China University of Petroleum (Huadong), China

    16:45-17:30

    Panel Discussion

    Session 1-3: Protein-Protein Interactions and Protein-Transduction
    Time: March 22, 2010 08:30-12:10

    Session Chair:

    Dr. Mario Rivera, Professor of Chemistry, The University of Kansas, USA

    Co-Chair:

    Dr. Moonsoo Jin, Biomedical Engineering, Cornell University, USA

    08:30-08:55

    Title: Protein Dynamics and Protein-Protein Interaction Processes at Play in the Traffic of Iron In and Out of the Bacterioferritin Cavity
    Dr. Mario Rivera, Professor of Chemistry, The University of Kansas, USA

    08:55-09:20

    Title: Structure-based Design of a D-amino Acid Peptide Inhibitor of Tau Fibrillation
    Dr. John Karanicolas, Assistant Professor, University of Kansas, USA

    09:20-09:45

    Title: In Vivo Detection of Protein-Protein Interactions: Application to the Engineering of Activation-Specific Antagonist against Integrins
    Dr. Moonsoo Jin, Biomedical Engineering, Cornell University, USA

    09:45-10:05

    Coffee Break

    10:05-10:30

    Title: Evidence for a Protein-Protein Interaction between Human Serum Transferrin and Ceruloplasmin
    Dr. Thanh Ha Duong, Laboratoire ITODYS, Université Paris, France

    10:30-10:55

    Title: Engineered Fluorescent and Bioluminescent Proteins to Visualize Biological Function in Living Cells
    Dr. Takeaki Ozawa
    , Professor of Chemistry, Department of Chemistry, School of Science, The University of Tokyo, Japan

    10:55-11:20

    Title: Protein Biotinylation: An Example of a Post-translational Modification of Exceptional Specificity
    Dr. Steven Polyak, The University of Adelaide, Australia

    11:20-11:45

    Title: Detections of p53 cDNA and p53 Protein Mutation in Cancer Cell Lysates Using Surface Plasmon Resonance
    Dr. Feimeng Zhou,
    Professor, California State University, USA

    11:45-12:10

    Panel Discussion

    Session 1-4: Proteins Interacting with DNA and RNA
    Time: March 22, 2010 08:30-12:10

    Session Chair:

    Dr. Ching-Hwa Kiang, Physics & Astronomy, Rice University, USA

    Co-Chair:

    Dr. Philippe Collas, Professor of Medical Biochemistry, University of Oslo, Norway

    08:30-08:55

    Keynote Speaker:
    Title: Protein and DNA Interactions Studied Using Single-Molecule Manipulation
    Dr. Ching-Hwa Kiang, Physics & Astronomy, Rice University, USA

    08:55-09:20

    Title: Coupling of Endonuclease and Translocase Functions in Type I Restriction-Modification Complexes
    Dr. Rudiger Ettrich, Associate Professor, Department of Structure and Function of Proteins, Institute of Systems Biology and Ecology, Academy of Sciences of the Czech Republic, Czech Republic

    09:20-09:45

    Title: Biophysical Studies of mRNA-binding Proteins Involved in the Regulation of Gene Expression
    Dr. Jacqueline Anne Wilce, Assistant Professor, Department of Biochemistry & Molecular Biology, Monash University, Australia

    09:45-10:10

    Title: Analyzing DNA-protein Interactions in Small Cell Numbers and Biopsies by Chromatin Immunoprecipitation
    Dr. Philippe Collas, Professor of Medical Biochemistry, University of Oslo, Norway

    10:10-10:30

    Coffee Break

    10:30-10:55

    Title: Selectivity of Metal Ion Binding Specifically Drives the Interaction of a Ni2+-sensor with its Operator DNA
    Dr. Barbara Zambelli, Research Associate, Agro-Environmental Science and Technology, University of Bologna, Italy

    10:55-11:20

    Title: Restriction-Modification Systems as Selfish Mobile Elements
    Dr. Ichizo Kobayashi, Professor,University of Tokyo, Japan

    11:20-11:45

    Title: Helicobacter Pylori Restriction Modification systems: Role beyond Genome Protection
    Dr. Desirazu N Rao, Professor, Department of Biochemistry, IndianInstitute of Science, India

    11:45-12:10

    Title: Character of Tumor Associated Protein Recognized by Monoclonal Antibody to Yunnan Gejiu Lung Cancer
    Dr. Wang Qinqin, Director, Clinical Research Center, Kunming Medical college, China


    Session 1-5: Structure Biology, Protein Structure, Dynamics and Functions (Part Ⅰ)
    Time: March 22, 2010 13:30-17:30

    Session Chair:

    Dr. Hao Wu, Professor of Biochemistry and Structural Biology, Department of Biochemistry , Weill Medical College of Cornell University, USA

    Co-Chair:

    Dr. Richard W. Kriwacki, Adjunct Associate Professor, Department of Structural Biology, St. Jude Children's Research Hospital, USA.

    13:30-13:55

    Title: Asymmetric Interactions in Death Domain Oligomerization
    Dr. Hao Wu, Professor of Biochemistry and Structural Biology, Department of Biochemistry, Weill Medical College of Cornell University, USA

    13:55-14:20

    Title: Crystal Structures of Apo and Liganded Biotin Protein Ligase from Staphylococcus Aureus
    Dr. Matthew Charles James Wilce, Head of Structural Biology, Monash University, Australia

    14:20-14:45

    Title: Residue Structural Environment Descriptors and Fold Recognition
    Dr. Malak Pirtskhalava,
    Head of the Department of Structural Bioinformatics, Institute of Molecular Biology and Biological Physics, Republic of Georgia

    14:45-15:10

    Title: Role of Intrinsic Protein Flexibility in Regulatory Mechanisms
    Dr. Richard W. Kriwacki, Adjunct Associate Professor, Department of Structural Biology, St. Jude Children's Research Hospital, USA

    15:10-15:30

    Coffee Break

    15:30-15:55

    Title: Computational Modelling of Protein Dynamics under External Stress
    Dr. Irene Yarovsky, Professor, Discipline Head (Research)-Physics, School of Applied Sciences, RMIT University, Australia

    15:55-16:20

    Title: Protein Supramolecules and Peptide Serving in Nanotechnology
    Dr. Ichiro Yamashita, Professor, Nara Institute of Science and Technology, Japan

    16:20-16:45

    Title: Thermodynamic and Biochemical Characteristics of Myoglobins from Aquatic Animals
    Dr. Yoshihiro OCHIAI, Professor, Lab. Aquatic Bioscience, The University of Tokyo, Japan

    16:45-17:10

    Title: S-layer Assembly
    Dr. Seong-Ho Shin, Lawrence Berkeley National Laboratory, USA

    17:10-17:30

    Panel Discussion

    Session 1-6: Membrane Proteins
    Time: March 23, 2010 08:30-12:10

    Session Chair

    Dr. Dirk Zimmermann, Global Development Lead, Assay & System Platform Program, Roche Diagnostics Ltd., Switzerland

    Co-Chair

    Dr. Jan Kubicek, QIAGEN GmbH, Germany

    08:30-08:50

    Keynote Speaker:
    Title: Membrane Proteins: From Atomic Structure to in Situ Arrangement
    Dr. Werner Kuehlbrandt,
    Director, Department of Structural Biology, Max Planck Institute of Biophysics, Germany

    08:50-09:10

    Title: Insights into Structure and Function of Membrane Transport Proteins by Protein Chemical and Electron Paramagnetic Resonance Spectroscopic Approaches
    Dr. Heinrich Jung, Professor, Department of Biology I, Ludwig Maximilians University, Germany

    09:10-09:30

    Title: Lipids as Topological Determinants of Membrane Proteins
    Dr. William Dowhan, Professor, Department of Biochemistry & Molecular Biology, Medical School, University of Texas-Houston, USA

    09:30-09:50

    Title: Stability of Membrane Proteins as Probed by High-Pressure Spectroscopy
    Dr. Arvi Freiberg, Professor of Biophysics and Plant Physiology, University of Tartu, Estonia, Estonia

    09:50-10:10

    Title: Electrofused Expressions Systems and Their Capability for Membrane Protein Characterisation Demonstrated by the Elucidation of the Molecular Properties of Channelrhodopsin-2
    Dr. Dirk Zimmermann, Global Development Lead, Assay & System Platform Program, Roche Diagnostics Ltd., Switzerland

    10:10-10:30

    Coffee Break

    10:30-10:50

    Title: A New Method for Automated Crystallization of Membrane Proteins
    Dr. Jan Kubicek, QIAGEN GmbH, Germany

    10:50-11:10

    Title: Methods in Beta-barrel Membrane Protein Crystallization and the Structure of PorB from Neisseria Meningitidis
    Dr. Tina Iverson, Assistant Professor of Pharmacology, Vanderbilt University, USA

    11:10-11:30

    Title:AFM-based Investigations on the Interaction between Single Alpha-synuclein Peptides and Supported Lipid Bilayers
    Dr. Frank W. S. Stetter, Department of Biophysics and Institute for Medical Engineering, Technical University of Munich, Germany

    11:30-11:50

    Title: Membrane Protein Structure Prediction
    Dr. William Bret Church, Department of Pharmaceutical Chemistry, University of Sydney, Australia

    11:50-12:10

    Title: Peripheral Membrane Protein Structure and Function: Lessons from Phospholipase A2 and Lipoxygenase
    Dr. Suren A. Tatulian, Department of Physics, University of Central Florida, USA

    Session 1-7: Proteins and Signaling
    Time: March 23, 2010 08:30-12:10

    Session Chair

    Dr. Chris Proud, Professor, Human Genetics Division, University of Southampton, UK

    Co-Chair

    Dr. Xuemin Wang, Department of Biological Sciences, University of Southampton, UK

    08:30-08:55

    Title: G Protein Coupled Receptors and Signaling in Hypothalamic GnRH Neurons
    Dr. Lazar Krsmanovic, Staff Scientist, Section on Hormonal Regulation, PDEGEN, NICHD, NIH, USA

    08:55-09:20

    Title: Regulation of G Protein Signaling by the 70kDa Heat Shock Protein
    Dr. William Lim, Associate Professor, Faculty of Medicine and Health Sciences, University Malaysia Sarawak, Malaysia

    09:20-09:45

    Title: Modulation of Choilnergic Receptor Signaling by Snake Neurotoxis
    Dr. Yuri Utkin,
    Professor, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Russia

    09:45-10:10

    Title: Small Molecules, Big Impacts: Quorum-Sensing Signaling in Bacterial Social Behaviors
    Dr. Yung-Hua Li,
    Associate Professor, Dalhousie University, Canada

    10:10-10:30

    Coffee Break

    10:30-10:55

    Title: mTORC Signalling and the Regulation of Protein Synthesis
    Dr. Xuemin Wang, Department of Biological Sciences, University of Southampton, UK

    10:55-11:20

    Title: Quantitative Lipid Raft Proteomics of Caveolae and Non-Caveolar Caveolin-1
    Dr. Michelle Hill, NHMRC Research Fellow, The University of Queensland, Australia

    11:20-12:10

    Panel Discussion

    Session 1-8: Protein Trafficking/ Transport/ Translocation, Assembly
    Time: March 23, 2010 08:30-11:00

    Session Chair:

    Dr. Wong Siew Heng, Assistant Professor, National University Health System, Singapore

    Co-Chair:

    Dr. J. David Van Horn, Assistant Professor of Chemistry, University of Missouri-Kansas City, USA

    08:30-08:50

    Title: Different Roles for Chaperones and Scaffolds in GPCR Homo and Heterodimeric Receptor Complexes Assembly and Functions
    Dr. Denis J. Dupré, Assistant Professor, Dalhousie University, Canada

    08:50-09:10

    Title: Zonula Occludens Toxin and Its Derivatives Show Potential Success as Novel Absorption Enhancers Improving Drug Delivery
    Dr. Noha Nabil Salama, Assistant Professor, Basic and Pharmaceutical Sciences, St. Louis College of Pharmacy, USA

    09:10-09:30

    Title: Can Uranium Be Transported by the Iron Acquisition Pathways?
    Dr. Miryana Hemadi, Assistant Professor, Department of Laboratoire ITODYS, Université Paris-Diderot – CNRS, France

    09:30-09:50

    Title: Molecular Mechanism of Co-translational Protein Transport - a Tale of Two GTPases
    Dr. Shu-ou Shan, Assistant Professor, California Institute of Technology, USA

    09:50-10:10

    Title: Aggregation Mediated Sorting of Vacuolar Proteins into Transport Vesicles at the cis-Golgi Apparatus of Developing Plant Embryos
    Dr. Giselbert Hinz, Department of Cell Biology, Heidelberg Institute for Plant Sciences, University of Heidelberg, Germany

    10:10-10:30

    Title: ESCRT, Autophagy, and Frontotemporal Dementia
    Dr. Jin-A Lee, Assistant Professor , College of Life Science and Nano Technology, Department of Biotechnology, Hannam University, Republic of Korea

    10:30-10:50

    Title: Caspases Regulate Phagocytosis in Maturing Dendritic Cells
    Dr. Wong Siew Heng, Assistant Professor, National University Health System, Singapore

    10:50-11:00

    Coffee Break

    Session 1-9: Protein Splicing and Endo-and Exocytosis
    Time: March 23, 2010 11:00-12:10

    Session Chair

    Dr. Wei Guo, Associate Professor of Biology, University of Pennsylvania, USA

    Co-Chair

    Dr. Debbie C. Thurmond, Associate Director, Herman B Wells Center for Pediatric Diabetes Research, Indiana University School of Medicine, USA

    11:00-11:20

    Title: Molecular Machinery and Mechanisms Regulating Membrane Fusion
    Dr. Thomas S?llner, Professor, Heidelberg University Biochemistry Center, Germany

    11:20-11:40

    Title: Vesicle Exocytosis Mechanisms Gone Awry in Disease: New Insights into Old Mechanisms
    Dr. Debbie C. Thurmond, Associate Director, Herman B Wells Center for Pediatric Diabetes Research, Indiana University School of Medicine, USA

    11:40-12:00

    Title: The Exocyst Complex in Polarized Exocytosis
    Dr. Wei Guo, Associate Professor of Biology, University of Pennsylvania, USA

    Session 1-10: Protein Modifications and Metabolism
    Time: March 23, 2010 13:30-17:30

    Session Chair

    Dr. Birgit Kersten, Head of the GabiPD Team, Bioinformatics, Max Planck Institute for Molecular Plant Physiology, Germany

    Co-Chair

    Dr. Ganesh Kumar Agrawal, Associate Director, Research Laboratory for Biotechnology and Biochemistry (RLABB), Nepal

    13:30-13:55

    Title: Detecting, Locating and Sequencing Protein Post-translational Modifications Using High Performance TOF Mass Spectrometry
    Dr. James Langridge, Director Proteomics, Waters Corporation, UK

    13:55-14:20

    Title: Proteome-wide Phosphorylation Patterns in Arabidopsis Thaliana and the Effect of Single Nuclear DNA Polymorphisms
    Dr. Birgit Kersten, Head of the GabiPD Team, Bioinformatics, Max Planck Institute for Molecular Plant Physiology, Germany

    14:20-14:45

    Title: Methylation of Lysines on Histone Tails: Implications for Gene Regulation and Developmental Biology
    Dr. Reidunn Aalen, Professor, Department of Molecular Biosciences, University of Oslo, Norway

    14:45-15:10

    Title: C. elegans CDC-48/p97 Controls Germline-specific Sex Determination
    Dr.
    Kunitoshi Yamanaka, Associate Professor, Department of Molecular Cell Biology, Institute of Molecular Embryology and Genetics, Kumamoto University, Japan

    15:10-15:30

    Coffee Break

    15:30-15:55

    Keynote Speech:
    Title:
    Porosome: The Universal Secretory Machinery in Cells
    Dr. Bhanu P. Jena, Associate Secretary General, International Federation of Cell Biology, George E. Palade University Professor & Distinguished Professor, Department of Physiology, Wayne State University School of Medicine; Director, NanoBioScience Institute, USA

    15:55-16:20

    Title: Histone Purification in the Blink of an Eye from Whole and Undisturbed Cells While Preserving Histone Native Biomarkers
    Dr. Pedro Rodriguez-Collazo, Research Assistant Professor, Cell Biology and Physiology, University of Pittsburgh, USA

    16:20-16:45

    Title: Hypoxic Silencing of Tumor Suppressors by Epigenetic Mechanism in Cancer Progression
    Dr. You Mie Lee, Associate Professor, Department of Natural Sciences, School of Life Sciences and Biotechnology, Kyungpook National University, Republic of Korea

    16:45-17:10

    Title: How Can Enzymology Be Used for Agricultural Improvement Strategies
    Dr. Stephen MG Duff, Senior Research Scientist, Monsanto, USA

    17:10-17:30

    Title: Global In Vivo Phosphoproteomics of Developing Oilseed Discovers Extensive Phosphorylation in Metabolic Networks
    Dr. Ganesh Kumar Agrawal, Associate Director, Research Laboratory for Biotechnology and Biochemistry (RLABB), Nepal

    Session 1-11: Intrinsically Disordered Porteins
    Time: March 23, 201013:30-17:30

    Session Chair

    Dr. Peter Tompa, Group Leader, Hungarian Academy of Sciences, Hungary

    Co-Chair

    Dr. A. Keith Dunker, T-K Li Professor of Medical Research, Indiana University, Founder/Father of The Protein Trinity, USA

    13:30-13:55

    Title: Structural Disorder and Viability of Aberrant Cellular Proteins
    Dr. Peter Tompa, Group Leader, Hungarian Academy of Sciences, Hungary

    13:55-14:20

    Title: Prediction of Disordered Proteins and Disordered Binding Regions
    Dr. Zsuzsanna Dosztányi, Senior Scientist, Institute of Enzymology, BRC, Hungarian Academy of Sciences, Hungary

    14:20-14:45

    Title: Structural Stability and Functional Remodeling of Plasma Lipoproteins: Functional Role of Structural Disorder
    Dr. Olga Gursky, Associate Professor, Physiology and Biophysics
    Boston University School of Medicine, USA

    14:45-15:10

    Title: Origin of the Enhanced Binding Rates for Intrinsically Disordered Proteins
    Dr. Zhirong Liu, Associate Professor, College of Chemistry and Molecular Engineering, Peking University, China

    15:10-15:30

    Coffee Break

    15:30-15:55

    Title: Pup, a Prokaryotic Ubiquitin-like Protein, is an Intrinsically Disordered Protein
    Dr. Xiaoming Tu, Associate Professor, School of Life Sciences, University of Science and Technology of China, China

    15:55-16:20

    Title: The EWS Family of Oncoproteins: Uncovering the Hidden Structure
    Dr. Kevin A. W. Lee, Associate Professor, Department of Biology, Hong Kong University of Science and Technology, China

    16:20-16:45

    Title: Development of an Order/Disorder Assignment Method for Protein Molecules and its Application to the Human Proteome
    Dr. Ken Nishikawa, Professor,Department of Bioinformatics, Maebashi Institute of Technology, Japan

    16:45-17:10

    Title: NMR Delineation of Pre-Structured Motifs(PreSMos)in Intrinsically Unfolded Proteins(IUPs)
    Dr. Kyou-Hoon Han, Senior Investigator,KRIBB, Korea

    17:10-17:30

    Panel Discussion

    Session 1-12: Structure Biology, Protein Structure, Dynamics and Functions (Part Ⅱ)
    Time: March 23, 2010 13:30-17:30

    Session Chair

    Dr. Maria Celeste Sagui, Professor, Department of Physics, North Carolina State University, USA

    Co-Chair

    Dr. Wei Feng, Professor, Institute of Biophysics, Chinese Academy of Sciences, China

    13:30-13:55

    Title: Structural Biology and Inhibition of Enzymes that Assemble Outer Membrane lipids in E. coli: Targets for New Antibiotics
    Dr. Christian R. H. Raetz,
    George Barth Geller Professor, Department of Biochemistry, Duke University Medical Center; Member, National Academy of Sciences of the United States of America, USA

    13:55-14:20

    Title: Calculating Free Energy Landscapes of Helix-Forming Peptides Using An Adaptively Biased Molecular Dynamics Method
    Dr. Maria Celeste Sagui, Professor, Department of Physics, North Carolina State University, USA

    14:20-14:45

    Title: Quantifying Conformational Flexibility and Dynamics in Protein Families
    Dr. Andrew J. Rader, Assistant Professor, Department of Physics, Indiana University-Purdue University Indianapolis, USA

    14:45-15:10

    Title: Myosin VI Undergoes Cargo-Mediated Dimerization
    Dr. Wei Feng, Professor, Institute of Biophysics, Chinese Academy of Sciences, China

    15:10-15:30

    Coffee Break

    15:30-15:55

    Title: Molecular Dynamics of Human Serum Albumin Complexed with Fatty Acids
    Dr. Bruno Rizzuti, Associate Researcher, LiCryL INFM-CNR, Cemif.Cal , National Council of Research, Italy

    15:55-16:20

    Title: Evolution, Function and Structure of Leucine-rich Repeats
    Dr. Norio Matsushima, Professor, Sapporo Medical University, Japan

    16:20-16:45

    Title: Distill, Protein Structure Prediction by Machine Learning
    Dr. Gianluca Pollastri, School of Computer Science and Informatics and Complex and Adaptive Systems Labs, University College Dublin, Ireland

    16:45-17:10

    Title: Nature of Inter-NBD (Nucleotide Binding Domain) Communication in P-Glycoprotein, a Multi Drug Efflux Pump
    Dr. S.L.N. Prasad Reddy, Pharmaceutical Biotechnology, Samskruti College of Pharmacy, India

    17:10-17:30

    Panel Discussion


    Symposium 2: Protein Technologies

    Session 2-1: Protein Screening, Bioassay and Discovery
    Time: March 21, 2010 13:30-15:30

    Chair

    Dr. Jens R. Coorssen, Foundation Chair & Head, Molecular Physiology and the Molecular Medicine Program, University of Western Sydney, Australia

    13:30-13:55

    Title: A High Throughput Protein Binding Assay Based on Protein Stability
    Dr. Yi Wang, Chief Scientific Officer, Pharmadiscover Inc., China

    13:55-14:20

    Title: Refining Gel-based Proteomics to Optimize Analyses
    Dr. Jens R. Coorssen,
    Foundation Chair & Head, Molecular Physiology and the Molecular Medicine Program, University of Western Sydney, Australia

    14:20-14:45

    Title: Synthetic Peptide Based in Vitro Assay for Food Borne Toxins Detection as an Alternative to Animal Bioassay
    Dr. Reuven Rasooly, Research Chemist, United States Department of Agriculture, USA

    14:45-15:10

    Title: Identification of Food-Derived Peptides in Human Peripheral Blood -Good Candidate for Active Peptide with Health-Promotion Activity
    Dr. Kenji Sato, Professor, Kyoto Prefectural University, Japan

    15:10-15:30

    Coffee Break

    Session 2-2: Protein Chips, Arrays and Protein Structures in Silico
    Time: March 21, 2010 15:30-17:30

    Session Chair:

    Dr. Anthony R. White, Head, The University of Melbourne, Australia

    15:30-15:55

    Title: Microfluidics, Multiplexing and Workflow Integration for Next Generation Protein Analysis Platforms
    Dr. Thomas Li, Senior Director, Technology Management, Chief Technology Office, Roche Diagnostics, USA

    15:55-16:20

    Title: Investigating Metal-regulated Protein Expression Using Antibody Microarrays and Protein-protein Interaction Database Analysis
    Dr. Anthony R. White, Head, The University of Melbourne, Australia

    16:20-16:45

    Title: The Use of Amphipathic Polymers ('Amphipols') to Fold, Keep Soluble and Stabilize Membrane Proteins, and to Immobilize them onto Solid Supports
    Dr. Jean-Luc. POPOT, Director, CNRS/University Paris 7, France

    16:45-17:10

    Title: Biomolecules Array on Chip Using 2D Chemicla Modification of Self-assembly Monolayer
    Dr. Atsushi Kira,
    Supervisor, ULVAC Inc., Japan

    17:10-17:30

    Panel Discussion

    Session 2-3: NMR, EM and X-Ray Crystallography
    Time: March 22, 2010 08:30-12:10

    Session Chair:

    Dr. Ingeborg Schmidt-Krey, Professor, Georgia Institute of Technology, USA

    Co-Chair:

    Dr. Akira Naito, Professor, Yokohama National University, Japan

    08:30-08:55

    Title: Efficient Studies of Protein-protein Interactions by NMR Spectroscopy
    Dr. Gerhard Wider, Director of High Field NMR Laboratory, Swiss Federal Institute of Technology ETH Zurich, Switzerland

    08:55-09:20

    Title: Use of High Throughput Diffraction Capable Nanofluidic Chip in Protein Crystallization Screening and Hands-free X-ray Data Collection
    Dr. Hazelle Lam, Director, Fluidigm Corporation, USA

    09:20-09:45

    Title: Structure-Function Studies of the Membrane Protein Human Leukotriene C4 Synthase by Cryo-EM
    Dr. Ingeborg Schmidt-Krey, Professor, Georgia Institute of Technology, USA

    09:45-10:10

    Title: Dissecting the Three-dimensional Structure of the Power-generating Mechanism of the Bacterial Flagellar Motor
    Dr. Anna Roujeinikova, Associate Professor, Monash University, Australia

    10:10-10:30

    Coffee Break

    10:30-10:55

    Title: Purification and NMR Structural Characterization of Bovine Antimicrobial Peptide, Lactophoricin
    Dr. Yongae Kim, Professor, Hankuk University of Foreign Studies, Republic of Korea

    10:55-11:20

    Title: Structure Elucidation of Membrane-associated Peptides and Proteins Bound to Lipid Bilayers as Revealed by Solid-state NMR Spectroscopy
    Dr. Akira Naito, Professor, Yokohama National University, Japan

    11:20-11:45

    Title: NMR Experiments on Drug Candidates for the Sin3 Corepressor Bound to the Neural Repressor NRSF/REST Related to Meduloblastoma
    Dr. Yoshifumi Nishimura, Professor, Yokohama City University, Japan

    11:45-12:10

    Title: Structural Biology of Disease Related Proteoglycans by NMR and X-ray Crystallography
    Dr. Weontae Lee, Professor & Chairman, Yonsei University, South Korea

    Session 2-4: Cell Free Technologies for Proteins
    Time: March 22, 2010 13:30-15:50

    Session Chair:

    Dr. Yaeta Endo, Professor & Director, Cell-Free Science and Technology Research Center, Ehime University, Japan

    13:30-13:50

    Keynote Speaker
    Title: Advances in the Cell-Free Protein Production for Postgenome Sciences
    Dr.
    Yaeta Endo, Professor & Director, Cell-Free Science and Technology Research Center, Ehime University, Japan

    13:50-14:10

    Title: Synthesis of A Rtificially-functionalized Peptides Using Cell-free Translation Agoyaand in Vitro Selection Method
    Dr. Akira Wada, Research Scientist, Advanced Science Institute, RIKEN, Japan

    14:10-14:30

    Title: Isolation Technique and New Functions of Cell-free Protein in the Formation of Single Crystals in Calcified Endoskeleton
    Dr. M. Azizur Rahman, Associate Professor, University of the Ryukyus, Japan

    14:30-14:50

    Title: Cell-free Protein Synthesis at High Temperatures Using the Lysate of a Hyperthermophile
    Dr. Tamotsu Kanai, Assistant Professor, Kyoto University, Japan

    14:50-15:10

    Title: Cell-free Synthesis of the Torque Generating Bacterial Flagellar Motor Proteins
    Dr. Seiji Kojima, Assistant Professor, Nagoya University, Japan

    15:10-15:30

    Title: PURE System for Production and Creation of Biosystems in Vitro
    Dr. Takuya Ueda, Professor, Department of Medical Genome Sciences, The University of Tokyo, Japan

    15:30-15:50

    Coffee Break

    Session 2-5: Protein Separation and Purification Technologies
    Time: March 22, 2010 15:50-17:30

    Session Chair:

    Dr. Yaeta Endo, Professor & Director, Cell-Free Science and Technology Research Center, Ehime University, Japan

    15:50-16:10

    Title: In-Depth Analysis of Serum by Consecutive Depletion and Multi-Dimensional De-Complexing Followed by Nano-LC-MS/MS
    Dr. Manfred Raida, Group Leader, Experimental Therapeutics Centre, Singapore

    16:10-16:30

    Title: Discovery of Novel Calcium Oxalate Crystal Growth Inhibitory Proteins from Medicinal Plants by Mass Spectrometry
    Dr. Chanderdeep Tandon, Associate Professor, Jaypee University of Information Technology, India

    16:30-16:50

    Title: SFO Ultrasonic Assisted Enzymolysis of Wheat Germ for Preparation of the ACE Inhibiting Peptide and its Reaction Kinetics
    Dr. Haile Ma, Professor, School of Food and Biological Engineering, Jiangsu University, China

    16:50-17:10

    Title: Development of Novel Synthetic Hydrophilic Resin for Drug-protein Interaction Analysis
    Dr. Takao Isogai, Professor, The University of Tokyo, Japan

    17:10-17:30

    Title: Improving Recombinant Protein Purification Yield
    Dr. Heping Cao, Principal Research Scientist, United States Department of Agriculture, USA

    Symposium 3: Proteins and Diseases

    Session 3-1: Protein Interactions and Diseases
    Time: March 21, 2010 13:30-17:30

    Session Chair:

    Dr. Suk-Hwan Baek, Professor, Youngnam University, South Korea

    Co-Chair:

    Dr. Lian Li, Professor and Vice Chair, Emory University, USA

    13:30-13:55

    Title: Alpha-synuclein and its A30P Mutant Affect Actin Cytoskeletal Structure and Dynamics
    Dr. Evelina Chieregatti, Team Leader, The Italian Institute of Technology, Italy

    13:55-14:20

    Title: Parkin-Mediated Ubiquitin Signaling and Parkinson Disease
    Dr. Lian Li, Professor and Vice Chair, Emory University, USA

    14:20-14:45

    Title: The Role of Small Heat Shock Proteins in Amyloid Fibril-associated Diseases
    Dr.
    Heath Ecroyd, University of Wollongong, Australia

    14:45-15:10

    Title: The Interaction of ERK1/2 with Gbetagamma Subunits Triggers the Function of ERK1/2 towards Cardiac Hypertrophy
    Dr. Kristina Lorenz, Institute of Pharmacology and Toxicology, University of Würzburg, Germany

    15:10-15:30

    Coffee Break

    15:30-15:55

    Title: Role of NADPH Oxidase 1 in Toll-Like Receptor-Mediated Atherosclerosis
    Dr. Suk-Hwan Baek, Professor, Yeungnam University, South Korea

    15:55-16:20

    Title: Are Proprotein Convertases Therapeutic Targets for Prevention of Malignant Progression of MGUS?
    Dr. Alphons Vermorken, Professor, University of Leuven, Belgium

    16:20-16:45

    Title: Novel Self-association of the APC Molecule Affects APC Clusters and Cell Migration
    Dr. Zhuoyu Li, Professor, Shanxi University , China

    16:45-17:10

    Title: Molecular and Cellular Dysfunction of Spinocerebellar Ataxia Type 1 (SCA1) Disease
    Dr. Sunghoi Hong, Associate Professor, Korea University,South Korea

    17:10-17:30

    Title: Protein-protein Interaction and Disease
    Dr. Zhen-Lin Wang, Professor, Xi'an Jiaotong University, China

    Session 3-2: Protein Networks in Disease
    Time: March 21, 2010 16:00-17:20

    Session Chair:

    Dr. Celia R. S. Garcia, Professor, University of Sao Paulo, Brazil

    16:00-16:20

    Title: Analysis on Drug Interactions in Biochemical Networks
    Dr.
    Jose C. Nacher, Associate Professor, Future University Hakodate, Japan

    16:20-16:40

    Title: Dissecting Protein Signaling Network in Malaria Parasites
    Dr. Celia R. S. Garcia, Professor, University of Sao Paulo, Brazil

    16:40-17:00

    Title: Molecular Mechanism of RecQ Helicase Function in Human Cancers and Premature Aging Diseases
    Dr. Jin-Shan Hu, Associate Professor, Department of Basic Medical Sciences, Western University of Health Sciences, USA

    17:00-17:20

    Title: Expression and Regulation of Heat Shock Protein 70 During Chemical Anoxia in Fish and Mouse Cells.
    Dr. Carlo Gunnar Ossum, Scholar, University of Copenhagen, Denmark

    Session 3-3: Proteins in Apoptosis and Autophagy
    Time: March 22, 2010 08:30-10:55

    Session Chair:

    Dr. Shazib Pervaiz, Professor, National University of Singapore, Singapore

    08:30-08:50

    Title: Induction of Autophagy by Anthrax Lethal Toxin
    Dr. Aiguo Wu, Vice President, AFG Biosolutions Inc., USA

    08:50-09:10

    Title: Cancer Cell Mitochondrial Metabolism and the Anti-apoptotic Protein Bcl-2
    Dr. Shazib Pervaiz, Professor, National University of Singapore, Singapore

    09:10-09:30

    Title: Apaf-1 Function in Chemoresistant Ovarian Cancer
    Dr. J. Rebecca Liu, Associate Professor, University of Michigan Comprehensive Cancer Center, USA

    09:30-09:50

    Title: SET/I2PP2A Localization and Cell Death
    Dr. Bernadette Allinquant, Research Director, Université Paris-Descartes, France

    09:50-10:10

    Title: Selective Turnover of p62 by Autophagy
    Dr. Yoshinobu Ichimura,
    Assistant Professor, Juntendo University School of Medicine, Japan

    10:10-10:30

    Title: Autophagy in Development and Remodeling of Mammary Gland
    Dr. Malgorzata Gajewska, Warsaw University of Life Sciences, Poland

    10:30-10:50

    Title: Molecular Mechanisms of GNA-related Lectin-induced Apoptosis and Autophagy in Cancer Cells
    Dr. Bo Liu, Lecturer, Sichuan University, China

    10:50-10:55

    Coffee Break

    Session 3-4: Protein Misfolding and Cancers
    Time: March 22, 2010 10:55-12:15

    Session Chair:

    Dr. Shazib Pervaiz, Professor, National University of Singapore, Singapore

    10:55-11:15

    Title: Towards Targeting the Unfolded Protein Response in Human Melanoma
    Dr. Xu Dong Zhang, Conjoint Professor, Calvary Mater Newcastle Hospital, Australia

    11:15-11:35

    Title: Fourier Transform Infrared Spectroscopy to Monitor Protein Misfolding and Aggregation.
    Dr. Silvia Maria Doglia, Professor, Department of Biotechnology and Biosciences, University of Milano Bicocca, Italy

    11:35-11:55

    Title: A Model of Amyloid’s Role in Disease Based on Fibril Fracture
    Dr. Damien Hall, Assistant Professor, University of Tsukuba, Japan

    11:55-12:15

    Title: Endoplasmic Reticulum Stress as a Progression Factor for Kidney Disease
    Dr. Reiko Inagi,
    Senior Researcher, University of Tokyo School of Medicine, Japan

    Session 3-5: Protein Misfolding and Neurodegeneration
    Time: March 22, 2010 13:30-17:30

    Session Chair:

    Dr. Christian Griesinger, Professor, The Max Planck Institute for Biophysical Chemistry, Germany

    Co-Chair:

    Dr. Alfred Stracher, Chairman, Distinguished Professor of Biochemistry, State University of New York Downstate Medical Center at Brooklyn, USA

    13:30-13:55

    Keynote Speaker:
    Title:
    Calpain Inhibition to Treat Neurodegeneartive Diseases
    Dr.
    Alfred Stracher, Chairman, Distinguished Professor of Biochemistry, State University of New York Downstate Medical Center at Brooklyn, USA

    13:55-14:20

    Title: Polyglutamine Protein Misfolding and Neurodegeneration
    Dr.
    Xiao Jiang Li, Distinguished Professor, Emory University School of Medicine, USA

    14:20-14:45

    Title: The Mitigation of Protein Misfolding by Molecular Chaperone Proteins
    Dr. John Carver,
    Professor, School of Chemistry & Physics, The University of Adelaide, Australia

    14:45-15:10

    Title: Novel Calpain Inhibitors Protect Against the Neuropathologic Sequelae of Traumatic Brain Injury
    Dr. Douglas S. F. Ling,
    Associate Professor, SUNY Downstate Medical Center, USA

    15:10-15:30

    Coffee Break

    15:30-15:55

    Title: Cdk5 and Neuron Cell Death
    Dr. Shin-ichi Hisanaga, Professor, Tokyo Metropolitan University, Japan

    15:55-16:20

    Title: A Novel Protease (Calpain) Inhibitor for the Treatment of Neurodegenerative Diseases
    Dr. Getaw Hassen, Post-doctoral Fellow & Clinical Instructor , SUNY Downstate Medical Center, USA

    16:20-16:45

    Title: Structural Polymorphism of Tau Filaments
    Dr. Martin Margittai, Assistant Professor, Department of Chemistry and Biochemistry, University of Denver, USA

    16:45-17:10

    Title: New Trends in the Evolving Role of Unstructured Proteins in the Etiology of Distinct Human Diseases
    Dr.
    Ferenc Orosz, Senior Researcher, Hungarian Academy of Sciences, Hungary

    17:10-17:30

    Title: Regulation by Protein Phosphorylation in Bacterial Signal Transduction Systems
    Dr. Jeffry B. Stock, Departments of Molecular Biology and Chemistry, Princeton University, USA

    Session 3-6: Protein Therapeutics for Immunologic & Inflammatory Diseases
    Time: March 23, 2010 08:30-12:10

    Session Chair:

    Dr. Yoshinori Mine, Professor, University of Guelph, Canada

    Co-Chair:

    Dr. Fang Yan, Visiting Professor, Tianjin Medical University, China

    08:30-09:00

    Title: Dietary Peptide-based Intervention to Improve Chronic Inflammation
    Dr. Yoshinori Mine, Professor, University of Guelph, Canada

    09:00-09:30

    Title: Benefits of Oral Epidermal Growth Factor to Gut Health: A New Blockbuster?
    Dr. Andre G. Buret, Professor and Chair, University of Calgary, Canada

    09:30-10:00

    Title: Regulatory Roles of Amino Acids and Proteins in Immune Response of Inflammatory Bowel Disease
    Dr. Maiko Mori, Senior Scientist, Exploratory & Applied Pharmaceutical Research Department, Ajinomoto Co., Inc., Japan

    10:00-10:20

    Coffee Break

    10:20-10:50

    Title: Lactobacillus Rhamnosus GG-derived Soluble Proteins Prevent Intestinal Inflammation Through Activation of Epidermal Growth Factor Receptor Signaling Pathway
    Dr. Fang Yan, Visiting Professor, Tianjin Medical University, China

    10:50-11:20

    Title: Binding Mode and Selectivity of Endotoxin Variants
    Dr. Monique Sylvie Gangloff, Research Associate, University of Cambridge, UK

    11:20-12:10

    Panel Discussion

    Symposium 4: Human Proteome Technologies and Cancer Research

    Session 4-1: MS, Imaging MS and MALDI-TOF in Proteomics
    Time: March 21, 2010 13:30-16:00

    Session Chair

    Dr. J. Sabine Becker, Head of Trace and Ultratrace Analysis, Central Division of Analytical Chemistry, Germany

    Co-Chair

    Dr. Michael Sefkow, Head of Chemical Synthesis, Caprotec Bioanalytics GmbH, Germany

    13:30-13:50

    Keynote Speaker:
    Title: New Directions in Bioimaging Mass Spectrometry and Metallomics for Neurosciences
    Dr. J. Sabine Becker, Head of Trace and Ultratrace Analysis, Central Division of Analytical Chemistry, Germany

    13:50-14:10

    Title: Capture Compound Mass Spectrometry – an Novel Platform Technology for Functional Proteomics
    Dr. Michael Sefkow, Head of Chemical Synthesis, Caprotec Bioanalytics GmbH, Germany

    14:10-14:30

    Title: Multi Modality Imaging with Diversity Oriented Fluorescence Library Approach and MS Spectrometry
    Dr. Chang Young-Tae, Associate Professor, National University of Singapore, Singapore

    14:30-14:50

    Title: Discovery of Potential Tumor-associated Biomarkers in Human Thyroid and Kidney Carcinoma by Imaging Mass Spectrometry
    Dr. Kwang Pyo Kim, Associate Professor, Konkuk University, Republic of Korea

    14:50-15:10

    Title: Protein N- and C-Termini Identification Using Mass Spectrometry and Isotopic Labeling
    Dr. Bosong Xiang, Senior Scientist, Monsanto Company, USA

    15:10-15:30

    Title: TOF-SIMS Imaging of Biological Tissues
    Dr. Olivier Laprévote, Team Leader, Institute of Natural Products Chemistry, France

    15:30-15:50

    Title: Interactions of Metal-Based Anticancer Complexes with Albumin
    Dr. Fuyi Wang, Professor, Institute of Chemistry, Chinese Academy of Sciences, China

    15:50-16:00

    Coffee Break

    Session 4-2: Computational Proteomics and Bioinformatics
    Time: March 22, 2010 08:30-10:30

    Session Chair

    Dr. Scott Ely, Co-Director, Section of Hematopathology, Department of Pathology, Weill Medical College of Cornell University, New York Presbyterian Hospital, USA

    Co-Chair

    Dr. Shawn SC Li, Associate Professor, University of Western Ontario, Canada

    08:30-08:50

    Title: Efficient Web-Browsing for the Life-Scientist
    Dr. Reinhard Schneider, Team Leader, the EMBL Heidelberg, Data Integration and Knowledge Management, Germany

    08:50-09:10

    Title: Searching for Amyloid Conformations of Transthyretin with the Help of Unfolding Simulations and Bioinformatics Tools
    Dr. Rui M. Brito, Centre for Neurosciences and Cell Biology and Chemistry Department, Universidade de Coimbra, Portugal

    09:10-09:30

    Title: Localized Network Centrality and Essentiality in the Yeast–Protein Interaction Network
    Dr. Dongsup Kim, Associate Professor, Department of Bio and Brain Engineering, KAIST, Republic of Korea

    09:30-09:50

    Title: Proteomic Database of the Agarose 2-DE for High-Molecular-Mass (>200kDa) Proteins
    Dr. Masamichi Oh-Ishi, Associate Professor, Department of Physics, Kitasato University School of Science, Japan

    09:50-10:10

    Title: The Community Structure of Human Cellular Signaling Network
    Dr. Yuanbo Diao, Lecturer, College of Chemistry, Sichuan University, China

    10:10-10:30

    Coffee Break

    Session 4-3: Nanoproteomics, Chip and Array Technologies in Proteomics
    Time: March 22, 2010 10:30-12:10

    Session Chair

    Dr. Scott Ely, Co-Director, Section of Hematopathology, Department of Pathology, Weill Medical College of Cornell University, New York Presbyterian Hospital, USA

    Co-Chair

    Dr. Shawn SC Li, Associate Professor, University of Western Ontario, Canada

    10:30-10:50

    Title: A Method for Cancer Cell-Specific Protein Detection at the Single Cell Level
    Dr. Scott Ely, Co-Director, Section of Hematopathology, Department of Pathology, Weill Medical College of Cornell University, New York Presbyterian Hospital, USA

    10:50-11:10

    Title: Mapping Phosphotyrosine Signaling Network by Peptide and Protein Arrays
    Dr. Shawn SC Li, Associate Professor, University of Western Ontario, Canada

    11:10-11:30

    Title: Functional Proteomics Approach for Understanding Salinity Tolerance: Lessons From the Halotolerant Alga Dunaliella Salina
    Dr. Katz Adriana, Associate Staff Scientist, Department of Biological Chemistry, Weizmann Institute of Science, Israel

    11:30-11:50

    Title: Newly Designed Fluorescent Protein Probes and Application to Fully Automated 2D Electrophoresis System
    Dr. Kenji Yokoyama,
    Deputy Director, Biotechnology Industrialization Center, National Institute of Advanced Industrial Science and Technology, Japan

    11:50-12:10

    Title: Multivalent Chelators: Versatile Tools for Probing Protein Functions at Interfaces
    Dr. Changjiang You, Group Leader, Biology University of Osnabrück, Germany

    Session 4-4: Proteome Technologies and Breast Cancer, Colorectal and Colon Cancer
    Time: March 22, 2010 13:30-17:30

    Session Chair

    Dr. E.L. Iorio, President, International Observatory of Oxidative Stress, Italy

    13:30-13:50

    The: Novel Field of Redoxomics
    Dr.
    E.L. Iorio, President, International Observatory of Oxidative Stress, Italy

    13:50-14:10

    Title: Interrogation of the Colon Mitoproteome: Links with Obesity Related Cancer
    Dr. Janice Elizabeth Drew, Principal Investigator, Molecular Signalling Laboratory, Gut Health Department, Rowett Institute of Nutrition and Health, University of Aberdeen, Scotland

    14:10-14:30

    Title: The Role of Kallikrein-Related Peptidases in Colorectal Cancer
    Dr. Maroulio Talieri, Director, the Department of Cellular Physiology, "Saint Savas" Hospital, Greece

    14:30-14:50

    Title: Profiling Stress Proteome of Lactic Acid Bacteria
    Dr. Ozlem OSMANAGAOGLU, Associate Professor, Department of Biology, Ankara University, Turkey

    14:50-15:10

    Title: The Role and Regulation of Eukaryotic Translation Initiation Factor 5A2 (eIF5A2) in Liver Cancer and Implications for Treatment 
    Dr. Nikki P. Lee, Research Assistant Professor, Surgery, The University of Hong Kong, Hong Kong, China

    15:10-15:30

    Coffee Break

    15:30-15:50

    Title: Fluorescent Immunoprecipitation Assay as a Methodology for Profiling of Cell Membrane Protein Complexes
    Dr. Grigory Ivanovich Krotov, Senior Researcher, Antidoping Centre Moscow, Russia

    15:50-16:10

    Title: High Through-put Proteomic Tools for Cancer Biomarker Discovery
    Dr. Donghui Ma, OriGene Technologies Inc., USA

    16:10-16:30

    Title: Approach to Discover Screening Biomarker in Breast Cancer
    Dr. Dong-Young Noh,
    Professor of Department of Surgery, Chief of Comprehensive Cancer Center, Seoul National University & Seoul National University Hospital, Republic of Korea

    16:30-16:50

    Title: Molecular Classification of Breast Cancer and Role of Immunohistochemistry for Detection of Cell Types that Predicts Response to Chemotherapy with Santinib (P53)
    Dr. Mulazim Hussain Bukhari, Associate Professor, King Edward Medical Universiity, Pakistan

    16:50-17:10

    Title: The Bottlenecks and Solutions to High-throughput Protein Research Technology
    Mr. Lei Li,
    Product Specialist, Marketing, Gene Company Limited, China

    17:10-17:30

    Panel Discussion

    Session 4-5: Proteomics of Lung Cancer, Esophageal Cancer, Leukemia, Ovarian and Cervical Cancer
    Time: March 23, 2010 13:30-15:30

    Session Chair

    Dr. Marika Crohns, Specialist in Oncology and Radiotherapy, University of Tampere, Finland

    Co-Chair

    Dr. Qun Zhao, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, China

    13:30-13:50

    Title: Cytokines before and during Radiotherapy for Lung Cancer- Relationship of IL-8 and VEGF with Survival
    Dr. Marika Crohns, Specialist in Oncology and Radiotherapy, University of Tampere, Finland

    13:50-14:10

    Title: Regulation of Cancer by Therapeutic Vaccination and Dietary Bio-modulation Involving Organ Specific Mitochondria
    Dr. Faik Atroshi , Pharmacology & Toxicology, 00014 University of Helsinki, Finland

    14:10-14:30

    Title: Role of 3q26.2 Dysregulated Genes in Ovarian Cancer Development
    Dr. Meera Nanjundan, Assistant Professor, Department of Cell Biology, Microbiology and Molecular Biology (CMMB), USA

    14:30-14:50

    Title: High Molecular Weight Complex in Leukemia
    Dr. Elena Puccetti, Junior Group Leader, Institute for Molecular Biology and Tumor Research (IMT), Germany

    14:50-15:10

    Title: Proteomic-based Approach Identifying Autoantibody as a Novel
    Serum Marker in Esophageal Squamous Cell Carcinoma
    Dr. Yoshihisa Fujita, Assistant Professor, Department of General and Gastroenterological Surgery,
    Osaka Medical College, Japan

    15:10-15:30

    Title: Development of Proteomics in Human Cervical and Ovarian Cancer Research
    Dr. Qun Zhao, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, China

    Session 4-6: Proteomics of Hepatic and Pancreatic Cancer
    Time: March 23, 2010 15:30-17:50

    Session Chair

    Dr. Hwyda A. Arafat, Associate Professor, Co-Director, Department of Surgery, Pathology Anatomy and Cell Biology, Jefferson Medical College, USA

    Co-Chair

    Dr. Eyyad Hassan A Kamel, Director, Department of Alternative Medicine, Mushfa Research Center, Kingdom Saudi Arabia

    15:30-15:50

    Keynote Speaker:
    Title: Blood-based Exopeptidase Activities as Biomarkers for Prostate Cancer
    Dr. Paul Tempst, Professor and Director of Proteomics, Molecular Biology, Memorial Sloan-Kettering Cancer Center, USA

    15:50-16:10

    Title: Distinctive Changes in Serum Proteins Associated with Chronic Pancreatitis, Autoimmune Pancreatitis and Pancreatic Cancer: Identification of Potential Biomarkers
    Dr. Klaus Felix, Research Group Leader, Department of General Surgery, University of Heidelberg, Germany

    16:10-16:30

    Title: Expression and Roles of FGFR2 Isoforms in Pancreatic Cancer Cells
    Dr. Toshiyuki Ishiwata, Associate Professor, Department of Pathology, Integrative Oncological Pathology, Nippon Medical School, Japan

    16:30-16:50

    Title: Cymetiron (Hepron-BM) as Initial Treatment for Chronic Hepatitis C
    Dr. Eyyad Hassan A Kamel,
    Director, Department of Alternative Medicine, Mushfa Research Center, Kingdom Saudi Arabia

    16:50-17:10

    Title: Osteopotnin Isoform (OPNc): a Potential Marker in Pancreatic Ductal Adenocarcinoma
    Dr. Hwyda A. Arafat, Associate Professor, Co-director, Department of Surgery, Pathology Anatomy and Cell Biology, Jefferson Medical College, USA

    17:10-17:30

    Title: Anti-tumor Activities of Histone Deacetylase Inhibitors Against Various Cancers
    Dr. Takashi Kumagai, Director of Hematology, Ohme Municipal General Hospital, Clinical Asscociate Professor of Medicine, Tokyo Medical and Dental University, Japan

    17:30-17:50

    Title: Phosphoproteomics Exploration Reveals that FER Non-Receptor Tyrosine Kinase Plays a Regulative Role in the Metastasis of Hepatocellular Carcinoma Cell
    Dr. Haiyu Li, Instructor, Biochemistry & Molecular Biology, Shaoxing University, China

    Symposium 5: Protein Kinases

    Session 5-1: Protein Kinases and Kinome as Drug Targets-Preclinical to Clinical Trials
    Time: March 21, 201013:30- 15:00

    Session Chair

    Dr. Zhaohua Irene Tang, Associate Professor of Biology, Claremont Colleges, USA

    13:30-13:50

    Keynote Speaker:
    Title: Functional Interrogation of the Kinome in Drug Discovery
    Dr. John W. Kozarich, Chairman & President, ActivX Biosciences, Inc.; Chief Scientific Advisor, Kyorin Pharmaceutical Co., LTD., USA

    13:50-14:10

    Title: RAS-activated Kinases as Potential Anti-invasion Drug Targets in Cancer and Development of a New Chemical-genetic Platform for Rapid Generation of Specific Inhibitors of these and other Kinases
    Dr. Morten Frödin, Group leader, Biotech Research and Innovation Centre, University of Copenhagen, Denmark

    14:10-14:30

    Title: Systematic Analysis of Response Pathways to Phenol Derivatives as Environmental Factors at the Kinomic and Genomic Sales
    Dr. Zhaohua Irene Tang, Associate Professor of Biology, Claremont Colleges, USA

    14:30-14:50

    Title: Molecular Dynamics Simulations Suggest a Molecular-level Oncogenesis Mechanism Shared by Several Cancer Mutants of the EGF Receptor Kinase
    Dr. Yibing Shan, D.E. Shaw Research, USA

    14:50-15:00

    Coffee Break

    Session 5-2: Protein Kinase and Apoptosis
    Time: March 21, 2010 15:00- 17:20

    Session Chair

    Dr. Charles J. Malemud, Professor, Case Western Reserve University School of Medicine, USA

    15:00-15:20

    Keynote Speaker:
    Title: A New Point of Control of Apoptosis by C-abl: the Mitochondrial Proteins Mtaxin 1
    Dr. Francois Vallette, Director of Research INSERM (French National Institute of Health and Medical Research); Director of team 9 "apoptosis and tumor progression",Cancer Research Center of Nantes Angers, University of Nantes, France

    15:20-15:40

    Title: Death-Associated Protein Kinases (DAPKs) Inhibitors
    Ms. Masako Okamoto, Senior Scientist, Research & Development Division, PharmaDesign, Inc., Japan

    15:40-16:00

    Title: Post-translational Modifications Switch theFunctional of l Human Ribosomal Protein S3 in DNA Repair and Translation
    Dr. Joon Kim, Professor, Laboratory of Biochemistry, School of Life Sciences & Biotechnology, Korea University, Korea

    16:00-16:20

    Title: IL-6 Trans-signaling Regulation of Immune Responses and Inflammation in Rheumatoid Arthritis
    Dr. Charles J. Malemud, Professor, Case Western Reserve University, USA

    16:20-16:40

    Title: PI3 Kinase and Protein Kinase B (Akt) Play Central Roles in Regulating Intestinal Epithelial Cell Proliferation, Migration and Apoptosis: Implications in Intestinal Pathology
    Dr. Tamas Jilling, Research Associate Professor, The Ellrodt-Schweighauser Family Chair of Perinatal Research, NorthShore University HealthSystem, Research Institute, Evanston Hospital, USA

    16:40-17:00

    Title: Regulation of HIPK2-mediated Apoptosis by Poly-ubiquitination and SUMO-modification
    Dr. Cheol Yong Choi, Associate Professor, Department of Biological Science, Sungkyunkwan University, Republic of Korea

    17:00-17:20

    Title: Protocadherin Arcadlin Regulates Seizure-induced Synaptic Loss by Activating p38 MAP Kinase Signaling
    Dr. Shin Yasuda, Department of Neuropharmacology, Tokyo Metropolitan Institute for Neuroscience, Japan

    Session 5-3: Protein Kinase Inhibitors in Cancer
    Time: March 22, 2010 08:30-10:20

    Session Chair

    Dr. Maurizio Salvadori, Professor, University of Florence, Italy

    08:30-08:50

    Keynote Speaker
    Title: From Screening to Clinic, Discovery of a Novel Allosteric MEK Inhibitor
    Dr. Henry Yu, Senior Principal Investigator, Chemistry, EMD Serono Research Institute, Inc. , USA

    08:50-09:10

    Title: Antineoplastic Effect of Proliferation Signal Inhibitors: from Biology to Clinical Application
    Dr. Maurizio Salvadori, Professor, University of Florence, Italy

    09:10-09:30

    Title: Exploring FGFR4 as a Potential Drug Target for the Treatment of Hepatocellular Carcinoma
    Dr. Ho Han Kiat, Assistant Professor, Department of Pharmacy, National University of Singapore, Singapore

    09:30-09:50

    Title: The MEK/ERK Signaling Pathway Affects Turnover of an ABC Transporter, ABCG2, Which Causes Multidrug Resistance of Cells
    Dr. Yasuo Imai, Associate Professor, Department of Pathology, Dokkyo Medical University Koshigaya Hospital, Japan

    09:50-10:10

    Title: Biological Impact of Freezing Plk1 (polo-like kinase 1) in Its Inactive Conformation by a Novel Potent Type II Kinase Inhibitor
    Dr. Birgit Spankuch, Goethe-University, Medical School, Germany

    10:10-10:20

    Coffee Break

    Session 5-4: Protein Kinase and Cell Cycle Control
    Time: March 22, 2010 08:30-12:10

    Session Chair

    Dr. Rainer Hedrich, Professor, University of Wuerzburg, Biocenter, Germany

    08:30-08:55

    Title: Control of Mitosis by Unexpected Protein Kinases
    Dr. Claude Prigent, Director, IGDR, Research Institute of Genetics and Development, CNRS, France

    08:55-09:20

    Title: Activity of Guard Cell Anion Channel SLAC1 is Controlled by Drought-stress Signaling Kinase-phosphatase Pair
    Dr. Rainer Hedrich, Professor, University of Wuerzburg, Biocenter, Germany

    09:20-09:45

    Title: Protein Kinases in the Ion-transporting ATPases World: A Fascinating Talk about Energy Interconversion
    Dr. Adalberto Vieyra, Professor of Biophysics and Physiology, Head, Laboratory of Biological Physical Chemistry, Institute of Biophysics Carlos Chagas Filho and National Institute of Structural Biology and Bioimage, Brazil

    09:45-10:10

    Title: Role of PKC-iota in Cancer Cell Proliferation and Survival
    Dr. Mildred Acevedo-Duncan, Research Associate Professor, Department of Chemistry, USF, VA Research, USA

    10:10-10:30

    Coffee Break

    10:30-10:55

    Title: The Roles of Cell Cycle Proteins and Protein Kinase Inhibitors in Normal and Pathological Placental Development
    Dr. Emin Turkay Korgun, Associate Professor, Department of Histology and Embryology, Medical Faculty, Akdeniz University, Turkey

    10:55-11:20

    Title: Protein Kinase Activation and Cardioprotection by Regular Ethanol Consumption and Volatile Anesthetics
    Dr. Masami Miyamae, Department of Internal Medicine, Osaka Dental University, Japan

    11:20-12:10

    Panel Discussion

    Session 5-5: Receptor Tyrosine Kinases
    Time: March 22, 2010 13:30-17:30

    Session Chair

    Dr. Nancy L. Lewis, Director, Phase I Clinical Trial Program, Cooper Cancer Institute, USA

    Co-Chair

    Dr. Xi-Long Zheng, Associate Professor, Senior Scholar of Alberta Heritage Foundation for Medical Research, Department of Biochemistry and Molecular Biology, Libin Cardiovascular Institute of Alberta, Smooth Muscle Research Group, The University of Calgary, Canada

    13:30-13:55

    Title: The Insulin-Like Growth Factor Receptor as a Target for Novel Cancer Therapies
    Dr. Nancy L. Lewis, Director, Phase I Clinical Trial Program, Cooper Cancer Institute, USA

    13:55-14:20

    Title: Regulation of Cell Growth by Chloride Ion via MAPK-dependent Pathways
    Dr. Yoshinori Marunaka, Professor and Chairman, Molecular Cell Physiology, Kyoto Prefectural University of Medicine, Japan

    14:20-14:45

    Title: Signaling Pathways Controlling Epithelial Integrity and Shape
    Dr. Christian Dahmann, Group Leader, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany

    14:45-15:10

    Title: Differential Roles of the Mitogen-Activated Protein Kinase Pathway in Smooth Muscle
    Dr. Xi-Long Zheng, Associate Professor, Senior Scholar of Alberta Heritage Foundation for Medical Research, Department of Biochemistry and Molecular Biology, Libin Cardiovascular Institute of Alberta, Smooth Muscle Research Group, The University of Calgary, Canada

    15:10-15:30

    Coffee Break

    15:30-15:55

    Title: Function and Cell Surface Expression of insulin Receptor and IGF-I Receptor in Neuronal Cells
    Dr. Toshihiko Yanagita, Assistant Professor, Department of Pharmacology, Miyazki Medical College, University of Miyazaki, Japan

    15:55-16:20

    Title: When Phosphatases Support Kinases: Regulation of Bone Resorption in vivo by Protein Tyrosine Phosphatase Epsilon
    Dr. Ari Elson, Associate Professor, Department of Molecular Genetics, The Weizmann Institute of Science, Israel

    16:20-16:45

    Title: Role of Protein Kinases in the Regulation of Vascular Growth and Tumor Progression
    Dr. Yulong He, Principal Investigator, Laboratory of Vascular and Cancer Biology, Model Animal Research Institute, Nanjing University, China

    16:45-17:10

    Title: The Signaling Pathways and Biological Properties of Novel Oncogne with Kinase-domain (NOK)
    Dr. Li Liu, Professor, Microbiology, Institute of Basic Medical, Sciences, CAMS & PUMC, China

    17:10-17:30

    Panel Discussion

    Session 5-6: The EGF Receptor and Associated Signaling
    Time: March 22, 2010 13:30-17:30

    Session Chair:

    Dr. Anja Nohe, Assistant Professor, Department of Biological Sciences, Wolf Hall, University of Delaware, USA

    Co-Chair:

    Dr. Kenneth L. van Golen, Assistant Professor, Department of Biological Sciences, University of Delaware, USA
    13:30-13:50

    Title: Role of Co-receptors and of the Actin Cytoskeleton to Receptor Tyrosine Kinase Signaling
    Dr. Peter Herrlich,
    Professor of Molecular Biology Scientific Director, Leibniz Institute for Age Research - Fritz Lipmann Institute, Germany

    13:50-14:10

    Title: The Epidermal Growth Factor (EGF) Receptor in Inflammatory Breast Cancer Metastasis
    Dr. Kenneth L. van Golen, Assistant Professor, Department of Biological Sciences, University of Delaware, USA

    14:10-14:30

    Title: Role of BMPs and EGF-like Growth Factors in Regulating Ovarian Function
    Dr. Shunichi Shimasaki, Professor, Reproductive Medicine, University of California, San Diego, USA

    14:30-14:50

    Title: Regulation of EGF Signaling by Bone Morphogenetic Protein 2
    Dr. Anja Nohe, Assistant Professor, Department of Biological Sciences, Wolf Hall, University of Delaware, USA

    14:50-15:10

    Title: Regulation of Actin Cytoskeleton via EGF Signaling
    Dr. Laszlo Buday, Deputy Director, Institute of Enzymology, Biological Research Center, Hungary

    15:10-15:30

    Coffee Break

    15:30-15:50

    Title: Positive and Negative Modulators of EGF Receptor Signaling
    Dr. Laura Moro, Associated Professor, Lab of Applied Biology, DISCAFF, University of Piemonte Orientale “A. Avogadro”, Italy

    15:50-16:10

    Title: Nucleolin Interactions with ErbB Receptors: Effects on EGFR Activation and Anchorage Independent Growth
    Dr. Pinkas-Kramarski Ronit, Associate Professor, Department of Neurobiology, Tel-Aviv University, Israel

    16:10-16:30

    Title: Rotation/twist Model for the Molecular Mechanism underlying the Activation of the EGF/ErbB Receptor Family
    Dr. Ichiro Maruyama, Senior Investigator, Okinawa Institute of Science and Technology, Japan

    16:30-16:50

    Title: Modulation of Radiation Response via EGFR/HER-2 Associated Signaling
    Dr. In Ah Kim, Associate Professor, Seoul National University, School of Medicine, South Korea

    16:50-17:10

    Title: Two Phosphodegrons Targeting TAZ for SCFβ-TrCP Dependent Degradation in Response to Different Signals
    Dr. Qunying Lei, Molecular and Cell Biology Lab, Institutes of Biomedical Sciences, Fudan University, Shanghai, China

    17:10-17:30

    Title: MRL Proteins: Linking EGF Signalling to Tissue Growth, Invasive Cell Migration and Cancer Metastasis
    Dr. Daimark Bennett, University of Liverpool, UK

    Session 5-7: Bacterial Protein Kinases
    Time: March 23, 2010 08:30-10:40

    Session Chair

    Dr. Gottfried Unden, Professor, Microbiology and Wine Research, Johannes Gutenberg University, Germany

    08:30-08:50

    Title: Fine-tuning of a Histidine Kinase/Response Regulator System by Accessory Proteins in Escherichia Coli
    Dr. Kirsten Jung, Professor, Ludwig-Maximilians-Universitaet Muenchen, Germany

    08:50-09:10

    Title: Transmembrane Sensing His Kinase DcuS of Bacteria: Structural and Functional Aspects
    Dr. Gottfried Unden, Professor, Johannes Gutenberg-Universitat Mainz, Institut für Mikrobiologie und Weinforschung, Germany

    09:10-09:30

    Title: Threshold Level of a Sensor Histidine Kinase Governs Cell Fate in a Sporulating Bacterium
    Dr. Masaya Fujita, Assistant Professor, Department of Biology and Biochemistry, University of Houston, USA

    09:30-09:50

    Title: Molecular Basis for Light Regulation of Phototropin Kinase
    Dr. Satoru Tokutomi, Professor, Department of Biological Science, Graduate School of Science, Osaka Prefecture University, Japan

    09:50-10:10

    Title: Development of the Inhibitors Targeting WalK/WalR, Two-Component Signal Transduction System, Essential for Bacterial Cell Growth
    Dr. Ryutaro Utsumi, Professor, Bioscience, Graduate School of Agriculture, Kinki University, Japan

    10:10-10:30

    Title: Functional Analysis of Hisitidine Kinases in the Cyanobacterium Synechocystis sp. PCC 6803 Using Chimeric Sensor System
    Dr. Iwane Suzuki, Associate Professor, Graduate School of Life and Environmental Sciences, University of Tsukuba; Program Officer,  Grants-in Aid for Scientific Research (KAKENHI), Ministry of Education, Culture, Sports, Science and Technology, Japan

    10:30-10:40

    Coffee Break

    Session 5-8: The AKT/PI 3-Kinases, and The MAP Kinase Pathway
    Time: March 23, 2010 10:40-11:20

    Session Chair

    Dr. Gottfried Unden, Professor, Microbiology and Wine Research, Johannes Gutenberg University, Germany

    10:40-11:00

    Title: PTEN as a Suppressive Regulator in Folliculogenesis
    Dr. Akira Iwase, Assistant Professor, Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Japan

    11:00-11:20

    Title: The Role of Melanocortins in Adipocytes: from Fat to Facts
    Dr. Alexandra Gouveia, Investigator, University of Porto, Portugal

    Session 5-9: Protein Kinases as Targets for Metabolic Disease
    Time: March 23, 2010 11:30-12:20

    Session Chair

    Dr. Gottfried Unden, Professor, Microbiology and Wine Research, Johannes Gutenberg University, Germany

    11:20-11:40

    Keynote Speaker
    Title:
    Appetite Enhancement & Weight Gain by Peripheral TrkB Agonists in Non-human Primates
    Dr. John C. Lin, Executive Director, Research, Pfizer Inc. USA
    Presenter: Dr. David Tsao,
    Senior Scientist, Pfizer Inc. USA

    11:40-12:00

    Title: AMPK as a Drug Target in Metabolic Diseases - Molecular Approach to Drug Design
    Dr. Robert Jarzyna, Department of Metabolic Regulation, Institute of Biochemistry, Warsaw University, Poland

    12:00-12:20

    Title: Diabetes and Key Steps Downstream AMP Kinase
    Dr. F.R. van der Leij, Senior Lecturer in Molecular Biology, Life Sciences & Technology, Van Hall Larenstein & NHL University of Applied Sciences, The Netherlands

    Session 5-10: Wnt / Hedgehog / Notch Signaling Pathways
    Time: March 23, 2010 13:30-15:00

    Session Chair

    Dr. Roland Le Borgne, PI, Director of Resarch 2 (DR2) CNRS, Developmental Cell Biology, Université de Rennes, France

    13:30-13:55

    Title: Epsins and Notch Signaling in Mammals
    Dr. Ottavio Cremona, Professor of Human Anatomy Università Vita-Salute San Raffaele& IFOM - FIRC Institute of Molecular Oncology, Italy
    Presenter: Dr. Alessandra Zattit

    13:55-14:20

    Title: Drosophila Clathrin Adaptor AP-1 Complex Regulates Notch Dependent Binary Cell Fate Decisions
    Dr. Roland Le Borgne, PI, Director of Resarch 2 (DR2) CNRS, Developmental Cell Biology, Université de Rennes, France

    14:20-14:45

    Title: The H3K27me3-demethylase dUTX is a Suppressor of Notch-Induced Tumors in Drosophila
    Dr. Andreas Bergmann, MD Anderson Cancer Center, Department of Biochemistry & Molecular Biology,USA

    14:45-15:00

    Coffee Break

    Session 5-11: Kinase Screening, Profiling, Identification and Lead Optimization
    Time: March 23, 2010 15:00-17:30

    Session Chair

    Dr. Jiaan Yang, VP of Drug Discovery Technology, Sundia MediTech Company, Ltd., China

    15:00-15:25

    Keynote Speaker:
    Title: Genome Wide Analysis of Kinase Binding Site Signatures
    Dr. Abdelazize Laoui, Director Drug Design, Sanofi-Aventis, USA

    15:25-15:50

    Title: Bridging Cheminformatic and Bioinformatic Space via Kinase Profiling: A Data Mining Approach
    Dr. Yi Han, Sr. Principal Scientist, Discovery Chemistry, Hoffmann-La Roche Inc. USA

    15:50-16:15

    Title: Effective Screening Protein Database for Inhibitor and Kinase Binding Site with Quantitative Analysis
    Dr. Jiaan Yang, VP of Drug Discovery Technology, Sundia MediTech Company, Ltd., China

    16:15-16:40

    Title: Screening Kinase Inhibitors with Microarray-Based Optical Assay
    Dr. Zhenxin Wang, Professor of Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, China

    16:40-17:30

    Panel Discussion

    Session 5-12: Small Molecule Kinase Inhibitor Discovery
    Time: March 23, 2010 13:30-15:30

    Session Chair:

    Dr. Tomohisa NAGAMATSU, Professor and Head,Department of Drug Discovery and Development Division of Pharmaceutical Science Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama University, Japan

    Co-Chair:

    Dr. Peter P. Sayeski, Associate Professor, Department of Physiology and Functional Genomics, University of Florida College of Medicine, USA

    13:30-13:55

    Title: A Jak2 Tyrosine Kinase Inhibitor, G6, Suppresses Jak2-V617F Mediated Human Pathological Cell Growth
    Dr. Peter P. Sayeski, Associate Professor, Department of Physiology and Functional Genomics, University of Florida College of Medicine, USA

    13:55-14:20

    Title: Characterization of Upstream and Downstream Regulators of the MAP3K, MEKK3
    Dr. Rich Vaillancourt, Associate Professor, Department of Pharmacology & Toxicology, University of Arizona College of Pharmacy, USA

    14:20-14:45

    Title: Identifying and Targeting Intrinsic Cytoprotective Pathways as a Novel Rationale for Small Molecule Inhibitors to Treat Cancers
    Dr. Yun Dai, Assistant Professor, Virginia Commonwealth University/Massey Cancer Center, USA

    14:45-15:10

    Title: Structure-activity Relationships and Docking Simulation into Protein Tyrosine Kinase for Flavins and Their Analogs as a New Class of Antitumor Agents
    Dr. Tomohisa NAGAMATSU , Head of Molecular Pharmaceutical Chemistry Group, Department of Drug Discovery and Development, Division of Pharmaceutical Science, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
    Okayama University, Japan

    15:10-15:30

    Coffee Break

    Session 5-13: Translation Regulation in the CNS
    Time: March 23, 2010 15:30-17:30

    Session Chair

    Dr. Kobi Rosenblum, Professor, Chair, Department of Neurobiology & Ethology, Center for Gene & Brain, Mount Carmel, Haifa University, Israel

    15:30-15:55

    Keynote
    Title: Translational Control of Synaptic Plasticity and Learning and Memory
    Dr. Joel D. Richter, Professor, Program in Molecular Medicine, University of Massachusetts Medical School, USA

    15:55-16:20

    Title: Enhancing Cognitive Function via Modulation of the Brain PKR Activity
    Dr. Kobi Rosenblum, Professor, Department of Neurobiology, Center for Gene Manipulation in the Brain, University of Haifa, Haifa, Israel

    16:20-16:45

    Title: Abnormal Development and Maintenance of Brain White Matter in Mice Carrying Hypomorphyc eIF2B5 Allels
    Dr. Orna Elroy-Stein, Professor, Tel-Aviv University, Israel

    16:45-17:10

    Title: Translation Initiation and Elongation Factors in Neurological Health and Disease
    Dr. Christopher G. Proud, Professor of Cellular Regulation and Head, Biomolecular Sciences, Biological Sciences, University of Southampton, United Kingdom

    17:10-17:30

    Panel Discussion

    Symposium 6: Protein Based Drug Discovery

    Session 6-1: Target Discovery and Validations
    Time: March 21, 2010 13:30-15:00

    Session Chair:

    Dr. David H Solomon, President, Chief Executive Officer, ZEALAND Pharma A/S, Denmark

    Co-Chair:

    Dr. Xiayang Qiu, Director of Structural Biology, Biophysics and AB Computational Chemistry Pfizer Inc., USA

    13:30-13:50

    Title: Molecular Insights into Protein and Protein-Ligand Interactions to Impact Drug Discovery
    Dr. Xiayang Qiu, Director of Structural Biology, Biophysics and AB Computational Chemistry Pfizer Inc., USA

    13:50-14:10

    Title: Peptide Based Drug Discovery – the Zealand Model
    Dr. David H Solomon, President, Chief Executive Officer, ZEALAND Pharma A/S, Denmark

    14:10-14:30

    Title: RXP-E: A Cx43-binding Peptide that Prevents Action Potential Propagation Block
    Dr. Mario Delmar, Co-director, Center for Arrhythmia Research, Division of Cardiovascular Medicine, University of Michigan, USA

    14:30-14:50

    Title: Discovery of Novel Small Peptidomimetics that Prevent Cardiac Gap Junction Closure and Action Potential Propagation Block.  - From a 34 Amino Acid Peptide RXP-E to Active 3 Amino Acid Peptide Mimetics.
    Dr. Bjarne Due Larsen, Intellectual Property & Innovation, Medicinal Chemistry, Zealand Pharma A/S, Denmark

    14:50-15:00

    Coffee Break

    Session 6-2: GPCRs in Drug Discovery
    Time: March 21, 2010 15:00-17:30

    Session Chair:

    Dr. Annette Gilchrist, Assistant Professor, Pharmaceutical Sciences, Chicago College of Pharmacy, Midwestern University, USA

    Co-Chair:

    Dr. Betty Bei Yao, Senior Group Leader Neurological Disease Research, Global Pharmaceutical Discovery, Abbott Laboratories, USA

    15:00-15:20

    Title: Pharmacological Chaperones: An Emerging Therapeutic Approach for Hereditary Diseases Caused by Mutations in G Protein-coupled Receptors
    Dr. Ken Valenzano, Sr. Director, Pharmacology, Amicus Therapeutics, USA

    15:20-15:40

    Title: Cannabinoid CB2 Receptor as a Target for Pain Modulation
    Dr. Betty Bei Yao, Senior Group Leader Neurological Disease Research, Global Pharmaceutical Discovery, Abbott Laboratories, USA

    15:40-16:00

    Title: Orphan Receptors Looking for a Function through Receptor Hetero-oligomerization?
    Dr. Ralf Jockers, Research Director, INSERM, Institut Cochin, France

    16:00-16:20

    Title: Identification of a Metabolically Stable Chemerin Analog as a Useful Pharmacological Tool
    Dr. Shigeru Tokita, Research Group Manager, Molecular Biology, Taisho Pharmaceutical Co.,Ltd., Japan

    16:20-16:40

    Title: Characterization of Subtype-selective Melatoninergic Ligands with Novel Non-indole Scaffolds
    Dr. Maurice Kwok Chung HO, Senior Scientific Officer, Hong Kong University of Science and Technology, Hong Kong, China

    16:40-17:00

    Title: Bioinformatics Approaches toward Controlling Protein-Protein Interaction between GPCRs
    Dr. Wataru Nemoto, National Institute Advanced Industrial Science and Technology, Japan

    17:00-17:20

    Title: Allosteric Modulators of GPCRs
    Dr. Annette Gilchrist, Assistant Professor, Pharmaceutical Sciences, Chicago College of Pharmacy, Midwestern University, USA

    17:20-17:30

    Panel Discussion

    Session 6-3: Protein Structure, Modeling, and Fragment-Based Drug Discovery
    Time: March 22, 2010 08:30-10:00

    Session Chair:

    Dr. Hong Wang, Senior Principal Scientist, Pfizer Global R&D, USA

    Co-Chair:

    Dr. Jun Xu, Professor of Medicinal Chemistry, Sun Yat-Sen University; CEO of KMS Meditech, Inc., China

    08:30-08:50

    Keynote Speaker Invited
    Title: Biophysics in Fragment Screening: Combination is Key
    Dr. Matthias Frech, Research/ NCE Tech / LDT, Head of Molecular Interaction & Biophysics, Merck KGaA, Germany

    08:50-09:10

    Title: Medicinal Chemistry Inspired by TCM Informatics
    Dr. Jun Xu, Professor of Medicinal Chemistry, Sun Yat-Sen University; CEO of KMS Meditech, Inc., China

    09:10-09:30

    Title: Applications of Protein NMR in Fragment Based Drug Discovery
    Dr. Hong Wang, Senior Principal Scientist, Pfizer Global R&D, USA

    09:30-09:50

    Title: Computational Study of a Potentially Bioactive Peptide for the Treatment and Diagnosis of Multiple Sclerosis
    Dr. Carlo Guardiani, University of Florence, Italy

    09:50-10:00

    Coffee Break


    Session 6-4: Transmembrane Peptides as Novel Therapeutics
    Time: March 22, 2010 10:00-12:00

    Session Chair:

    Dr. Dominique Bagnard, INSERM U682, University of Strasbourg, France

    Co-Chair:

    Dr Hang Yin, University of Colorado, Boulder, USA

    10:00-10:20

    Title: Role of Interactions between Transmembrane Helices in Cell Signaling, More than Meets the Eye
    Dr. Pierre Hubert, CNRS, France

    10:20-10:40

    Title: Structural Aspects of transmembrane Helix Interactions: A Basis for Modulating Membrane Protein Folding, Stability and Function
    Dr. Dirk Schneider, Professor, Johannes Guttenberg-University Mainz, Germany

    10:40-11:00

    Title: Structural Requirements for APP Processing by g-secretase and Ab Oligomerization
    Dr. Kienlen-Campard Pascal, Associate Professor, University of Louvain, Belgium

    11:00-11:20

    Title: Transmembrane Peptide Targeting NRP1 as Efficient Anti-cancer Drug
    Dr. Dominique Bagnard, Assistant Professor, University of Strasbourg, France

    11:20-11:40

    Title: Self- assembly of Transmembrane Domains in CPT1: Role of GXXXG(A) Motif in Possible Channel Formation
    Dr. Ann M. Dixon, Associate Professor, University of Warwick, UK

    11:40-12:00

    Title: Rationally Designed Peptide Antagonists of the TLR4/MD2 Interaction
    Dr. Hang Yin, Assistant Professor, University of Colorado at Boulder, USA


    Session 6-5: Protein Drug Delivery System and Nanotechnologies
    Time: March 22, 2010 13:30-15:55

    Session Chair:

    Dr. Lee Henderson, CEO and Founder, Vybion, Inc., USA

    13:30-13:55

    Keynote
    Title:
    Current Trend of Protein Drug Delivery Systems
    Dr. Zeren Wang, Director, Pharmaceutics, Boehringer Ingelheim Pharmaceutics Inc, USA

    13:55-14:20

    Title: A Simple Protein Transduction Technique with Unique Novel Features
    Dr. Qianqian Li, Assistant Professor, Department of Biochemistry and Molecular Biology, School of Medicine, Wayne State University, USA

    14:20-14:45

    Title: The Possible Use of Virus-like Particle of Human Papillomavirus as a Drug Delivery Carrier Based on the Increase of Cellular Uptake of a Small Molecule
    Dr. Cheong-Weon Cho, Professor, Chungnam National University, Republic of Korea

    14:45-15:10

    Title: Site-specific PEGylation to the His-Tag of an Antibody Fragment
    Dr. Yuehua Cong, Research Project Manager, PolyTherics Ltd, UK

    15:10-15:30

    Title: Exploring Modular Protein Engineering As a Novel Approach for Gene Therapy
    Dr. Neus Ferrer-Miralles, Institut de Biotecnologia i Biomedicina, Universitat Autònoma de Barcelona, Spain

    15:30-15:55

    Coffee Break

    Session 6-6: Design Drugs Targeting Protein-Protein Interactions
    Time: March 22, 2010 15:55-17:30

    Session Chair:

    Dr. Lee Henderson, CEO and Founder, Vybion, Inc., USA

    15:55-16:20

    Keynote Speaker:
    Title:
    ProCode: A Novel Platform to Optimize Antibody Affinity and Solubility with Broader Applications in Drug Development
    Dr. Lee Henderson, CEO, Vybion, Inc., USA

    16:20-16:45

    Title: Interaction of Anti-Microbial Peptides with Membranes –an NMR and Computational Study
    Dr. Ulrich Sternberg, Professor, Karlsruhe Institute of Technology, Germany

    16:45-17:10

    Title: Discovery and Development of Peptides Targetting Malaria Apical Membrane Antigen 1 (AMA1)
    Dr. Andrew B. Hughes, Associate Professor,Department of Chemistry, La Trobe University, Australia

    17:10-17:30

    Panel Discussion

    Session 6-7: New Peptides Drug Discovery
    Time: March 23, 2010 08:30-12:10

    Session Chair:

    Dr. Waleed Danho, Distinguished Research Leader, Hoffmann-LaRoche Inc., USA

    Co-Chair:

    Dr. Henry H. Sun, Chairman and President, Tasly America Inc.; Vice President, Tasly Group, Co., Ltd., China

    08:30-08:55

    Keynote speaker:
    Title:
    Therapeutic Peptides: Opportunities and Challenges
    Dr. Waleed Danho, Distinguished Research Leader, Hoffmann-LaRoche Inc., USA

    08:55-09:20

    Title: A New Pipeline for Drug Discovery: Bioven – a Process for Predictive High-throughput Peptide Drug Discovery.
    Dr. Richard John Lipscombe, Director, Proteomics International, Australia

    09:20-09:45

    Title: CIS Display: An in vitro Display Technology for the Selection of Therapeutic Proteins
    Dr. Chris Ullman, CSO, Isogenica Ltd., UK

    09:45-10:10

    Title: Structure Modification for Enhanced Bio-activity and Mass Production by Genetic Engineering of Therapeutic Peptides
    Dr. Henry H. Sun, Chairman and President, Tasly America Inc.; Vice President, Tasly Group, Co., Ltd., China

    10:10-10:30

    Coffee Break

    10:30-10:55

    Title: Screening of Peptide Inhibitor Blocks Selectively the Interaction between Estrogen Receptors and Coactivators
    Dr. Trang T. P. Phan, Chemical Genomics Centre (CGC), Max-Planck Institute of Molecular Physiology, Germany

    10:55-11:20

    Title: Computer-Aided Design of Peptide Boronic Acid Proteasome Inhibitor
    Dr. Yongqiang Zhu, Senior Scientist, Process Chemistry, Simcere Pharmaceutical Group, China

    11:20-11:45

    Title: Corn Peptides as Alcohol Metabolism Stimulator and Hepatoprotective Agent
    Dr.
    Hui He, Professor, Huazhong Agricultural University, China

    11:45-12:10

    Panel Discussion

    Symposium 7: Protein Expression

    Session 7-1: Advances in Control of Gene Expression and Alternative Expression
    Time: March 21, 2010 13:30-15:30

    Session Chair:

    Dr. Liling Tang, Director, Chongqing University, China

    13:30-13:50

    Title: Post-Transcriptional Control of Chloroplast Gene Expression
    Dr.
    Eva Maria Del Campo Lopez, Professor, Department of Plant Biology, University of Alcalá, Spain

    13:50-14:10

    Title: Expression of IGF-I Alternative Splicing Variant Induced by Mechanical Signals and the Effects on the Physiological Behaviors of Osteoblasts
    Dr. Liling Tang, Director, Chongqing University, China

    14:10-14:30

    Title: Regulation of KNOX Gene Expression in Rice
    Dr. Yukihiro Ito, Associate Professor, Tohoku University, Japan

    14:30-14:50

    Title: Integrative Genomic Informatics of DNA Copy Number and Gene Expression Profiles Reveals Disease Pathways and Therapeutics Targets in Renal Cell Carcinoma
    Dr. Kazuhiko Uchida, Associate Professor, University of Tsukuba, Japan

    14:50-15:10

    Title: Gene Expression is a Circular Process
    Dr. Mordechai Choder, Faculty of Medicine, Technion - Israel Institute of Technology, Israel

    15:10-15:30

    Coffee Break

    Session 7-2: Eukaryotic/ Prokaryotic, Insect and Mammalian Expression
    Time: March 21, 2010 15:30-17:30

    Chair:

    Dr. George Lovrecz, Project Leader, CSIRO Molecular & Health Technologies, Australia

    15:30-15:50

    Title: Glycoprotein Production in Single -use and Conventional Bioreactors
    Dr. George Lovrecz, Project Leader, Molecular & Health Technologies, CSIRO, Australia

    15:50-16:10

    Title: Efficient Production of Disulfide Bonded Proteins in the Cytoplasm of E.coli
    Dr. Lloyd Ruddock, Professor of Protein Science, University of Oulu, Finland

    16:10-16:30

    Title: Antibiotic-free Selection in E. coli: New Considerations for Optimal Design and Improved Production
    Dr. Regis Sodoyer, Research Department, Sanofi Pasteur, France

    16:30-16:50

    Title: High Quality Protein Production in the Insect Cell-Baculovirus System
    Dr. Mónica Martínez Alonso, Institut de Biotecnologia i de Biomedicina, Autonomous University of Barcelona, CIBER-BBN, Spain

    16:50-17:10

    Title: A Robust System for Production of Recombinant Proteins in Bacillus Subtilis
    Dr. Hoang Duc Nguyen, Chemical Genomics Centre (CGC), Max-Planck Institute of Molecular Physiology, Germany

    17:10-17:30

    Title: An Integrated Systems Approach for Recombinant Microbial Bioprocess Development
    Dr.
    Monika Cserjan, Senior Scientist, University of Applied Life Sciences and Natural Resources, Austria

    Session 7-3: Novel Protein Expression Systems and Sample Purification, Detection Technologies
    Time: March 22, 2010 10:20-12:00

    Session Chair:

    Dr. Jianjun Wang, Associate Professor, Wayne State University, USA

    10:20-10:40

    Keynote Speech:
    Title: Baculovirus as a Versatile Tool for Protein Expression in Insect and Mammalian Cells
    Dr. Yu-Chan Chao, NSC Distinguished Research Fellow, Academia Sinica, Taiwan

    10:40-11:00

    Title: Engineered Micro-Algae to Produce Therapeutic Proteins
    Dr. Aude Carlier, CSO& Co-founder, Algenics, France

    11:00-11:20

    Title: A Gram Quantity Bacterial Expression Method Without a Fermentor
    Dr. Jianjun Wang, Associate Professor, Wayne State University, USA

    11:20-11:40

    Title: Recombinant Spider Silk - New Life in an Old Horse?
    Dr. Wilhelm Engstrom, Professor, Swedish University of Agricultural Sciences, Sweden

    11:40-12:00

    Title: Plasmid-free T7-based Escherichia Coli Expression Systems-a Robust and Efficient Alternative for Recombinant Protein Production
    Dr. Gerald Striedner, Senior Scientist, University of Applied Life Sciences and Natural Resources, Austria

    Symposium 8: Protein Biomarkers

    Session 8-1: Protein Biomarker Discovery and Validation for Diagnosis and Treatment
    Time: March 23, 2010 08:30- 10:35

    Session Chair

    Dr. Herbert Thiele, Director Bioinformatics, Bruker Daltonik GmbH, Germany

    Co-Chair

    Dr. Manfred Raida, Group Leader, Experimental Therapeutics Centre, Singapore

    08:30-08:50

    Title: Bioinformatics Strategies for Diagnosis and Biomarker Discovery in MALDI-TOF-MS? Profiles and MALDI TOF Images
    Dr. Herbert Thiele, Director Bioinformatics, Bruker daltonik GmbH, Germany

    08:50-09:10

    Title: Gb3, Lso-Gb3 and Metabolomic Studies Using Mass Spectrometry: How to Improve Monitoring of Fabry Disease Patients
    Dr. Christiane Auray-Blais, Director, Provincial Mass Urine Screening Program; Scientific Director, Waters-CHUS Expertise Centre in Clinical Mass Spectrometry, Department of Pediatrics, CHUS-Faculty of Medicine and Health Sciences, Université de Sherbrooke, Canada

    09:10-09:30

    Title: The Preeclampsia Biomarkers: Current Knowledge, Clinical Implications and Future Application.
    Dr. Olav Lapaire, Deputy of the Maternal-Fetal Unit, Department of Obstetrics and Gynecology, University of Basel, Switzerland

    09:30-09:50

    Title: Serological Identification of Alpha-Enolase as a Tumor-Associated Autoantigen and its Potential Medical Applications
    Dr. Neng-Yao Shih, Assistant Investigator, National Institute of Cancer Research, National Health Research Institutes, Taiwan

    09:50-10:10

    Title: Saliva Biochemical Markers for the Identification of Patients with Oral Cancer
    Dr. Satoru Shintani,
    Director, Department of Oral & Maxillofacial Surgery, Showa Univ. School of Dentistry, Japan

    10:10-10:30

    Title: ODAM – A Novel Biomarker for Epithelial Carcinomas
    Dr. Charles Todd Bruker, Department of Pathology, University of Tennessee Medical Center Knoxville, USA

    10:30-10:35

    Coffee Break

    Session 8-2: Toxicity Biomarkers and Biomarkers Assay Development
    Time: March 23, 2010 10:35-12:15

    Session Chair

    Dr. Paul Debbage, Professor, Department of Anatomy, Histology and Embryology, Medical University Innsbruck, Austria

    Co-Chair

    Dr. B. Sharma, Professor of Biochemistry &Chairman, Department of Biochemistry, Coordinator, Centre for Biotechnology, University of Allahabad, India

    10:35-10:55

    Title: Multiplex Assays for Biomarker Research and Clinical Application Translational Science Coming of Age
    Dr. Qin Fu, Director, Biomarker Validation, Johns Hopkins Bayview Proteomic Center, USA

    10:55-11:15

    Title: Possible Biomarkers for Methionine Excess Determination
    Dr. Ryosei Sakai, Chief Biochemist, Institute of Life Sciences, Ajinomoto Co., Inc., Japan

    11:15-11:35

    Title: A New Biomarker of Protein Oxidation Degree and Site Using Angiotensin as the Target by MS
    Dr. Rutao Liu,
    Professor, Deputy Dean, School of Environmental Sceince & Engineering, Shandong University, China

    11:35-11:55

    Title: Identification of Enzymatic Source of Alanine Aminotransferase Activity in Serum from Dogs with Liver Injury
    Dr. Masafumi Miyazaki, Infectious Diseases, Exploratory Research Laboratories, Kyorin Pharmaceutical Co., Ltd., Japan

    11:55-12:15

    Title: Biomarkers and Their Applications
    Dr. B. Sharma, Professor of Biochemistry &Chairman, Department of Biochemistry, Coordinator, Centre for Biotechnology, University of Allahabad, India

    Session 8-3: Protein Biomarkers for Cancers
    Time: March 23, 2010 13:30-15:20

    Session Chair

    Dr. Linsen Yang, Academic Marketing Manager, Marketing, Life Technologies, China

    Co-Chair

    Dr. Shan Lu, Assistant Professor, University of Cincinnati College of Medicine, USA

    13:30-13:50

    Title: Discovery of Urinary Biomarkers in Urinary Tract Carcinoma and Kidney Disease
    Dr. Vladisav Stefanovic, Professor, Internal Medicine, Nephrology, Clinical Research, University of Nis, Serbia

    13:50-14:10

    Title: An In Vitro Model to Study Chemoresistance in Non-Hodgkins Lymphoma Patients Over-expressing Mutant p53
    Dr. Diana Anderson, Professor, Established Chair in Biomedical Sciences, Division of Biomedical Sciences, School of Life Sciences, University of Bradford, UK

    14:10-14:30

    Title: Rb Expression - A Biomarker in Urinary Bladder Carcinoma
    Dr. Hans Olsson, Associate Professor, Pathology laboratory University hospital Linkoping, Sweden

    14:30-14:50

    Title: Hakai, An E-Cadherin Binding Protein, As a Novel Tissue Based Tumour Progression Marker
    Dr. Angélica Figueroa, Principal Investigator, Biomedical Research Institute (INIBIC), Medical Oncology Unit, A Coruka University Hospital, Spain

    14:50-15:10

    Title: Biomarkers in the Development of Novel Formulations in Nanomedicine
    Dr. Paul Debbage, Professor, Department of Anatomy, Histology and Embryology, Medical University Innsbruck, Austria

    15:10-15:20

    Coffee Break

    Session 8-4: Protein Biomarkers for Diseases: Cardiovascular, CNS, Inflammation and Immunology
    Time: March 23, 2010 15:20-17:00

    Session Chair

    Dr. Linsen Yang, Academic Marketing Manager, Marketing, Life Technologies, China

    Co-Chair

    Dr. Shan Lu, Assistant Professor, University of Cincinnati College of Medicine, USA

    15:20-15:40

    Title: Proteomic studies of Patients with Ocular Surface Inflammation Implicates the S100 A8/A9 proteins
    Dr. Roger Beuerman, Senior Scientific Director, Singapore Eye Research Institute (SERI), Singapore National Eye Center, Singapore

    15:40-16:00

    Title: Neuroproteomic Dementia Biomarkers: Status Quo and Perspectives
    Dr. Jens. Wiltfang, Professor, University of Duisburg-Essen, Germany

    16:00-16:20

    Title: Alteration of Histone Acetylation in the Retinas of Diabetes: A 2D-DIGE Study
    Dr. Ling Zheng, Professor of Pathology, College of Life Sciences, Wuhan University, China

    16:20-16:40

    Title: Biomarker Discovery: Advancing Discovery with ProtoArray Technology
    Dr. Linsen Yang, Academic Marketing Manager, Marketing, Life Technologies, China

    16:40-17:00

    Title: Gla Rich Protein (GRP), A New Biomarker For Ectopic Calcifications?
    Dr. Dina Costa Simes, GenoGla Diagnostics and University of Algarve/CCMAR, Portugal

    Session 8-5: Biomarker for Personalized Medicine
    Time: March 23, 2010 17:00-17:40

    Session Chair

    Dr. Agneta Siegbahn, Professor in Clinical Coagulation Science, Uppsala University, Department of Medical Sciences, Uppsala University, Sweden

    Co-Chair

    Dr. Shan Lu, Assistant Professor, University of Cincinnati College of Medicine, USA

    17:00-17:20

    Title: An Integrative Genomic and Proteomic Approach to Chemosensitivity Prediction
    Dr. Lan Guo, Assistant Professor of Community Medicine, Co-Director of WVU CTSI for Biomedical Informatics, Adjunct Assistant Professor of Computer Science, West Virginia University, USA

    17:20-17:40

    Title: Vav3 Oncogene Signaling in the EGFR/HER2-elicited Multiple Pathways in Development, Progression, and Theragnosis of Prostate Cancer
    Dr. Shan Lu, Assistant Professor, University of Cincinnati College of Medicine, USA

    Symposium 9: Protein as Biocatalysts and Biomaterials

    Session 9-1: Protein Design and Evolution for Enzymes
    Time: March 21, 2010 13:30-15:30

    Session Chair

    Dr. Bouzid Menaa, Research Program Director, Nanotechnology Division, Fluorotronics, Inc., USA

    13:30-13:50

    Title: Molecular Evolution in Quaternary Structure of an Essential Bacterial Enzyme
    Dr. Matthew Perugini, Senior Lecturer, Department of Biochemistry and Molecular Biology, University of Melbourne, Australia

    13:50-14:10

    Title: A Third Generation of Uronium and Phosphonium Type-Based Coupling Reagent
    Dr.
    Ayman El-Faham, Professor, King Saud University, Kingdom of Saudi Arabia

    14:10-14:30

    Title: Pig Liver Esterase - Re-introducing a Valuable Biocatalyst into Industrial Processes
    Dr.
    Harald Pichler, Assistant Professor, Graz University of Technology & Research Centre Applied Biocatalysis, Austria

    14:30-14:50

    Title: Genetically Enhanced Enzymes as Antibacterial Therapies
    Dr. Karl E. Griswold, Assistant Professor, Dartmouth College, USA

    14:50-15:10

    Title: Engineering Enzymes for Prodrug Activation Therapy
    Dr. Kristian M. Müller, Group Leader, Department of Biology, University of Freiburg, Germany

    15:10-15:30

    Coffee Break

    Session 9-2: Protein Biomaterial Design and Implications
    Time: March 21, 2010 15:30-17:30

    Chair

    Dr. Bouzid Menaa, Research Program Director, Nanotechnology Division, Fluorotronics, Inc., USA

    15:30-15:50

    Title: Proteins in Nanoporous Silica-based Sol-gel Glasses: from Bioencapsulation and Surface Adsorption to Protein Folding Studies
    Dr. Bouzid Menaa,
    Research Program Director, Nanotechnology Division, Fluorotronics, Inc., USA

    15:50-16:10

    Title: Polymer-Protein Hybrid Materials for Tissue Replacement
    Dr. Luiz Henrique Catalani, Professor & Leader, Laboratory of Polymeric Biomaterials, Institute of Chemistry, University of Sao Paulo, Brazil

    16:10-16:30

    Title: Corn Protein: a New Kind of Biomaterials as Bone Substitute
    Dr. Jinye Wang, Professor, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, China

    16:30-16:50

    Title: Bacterial Inclusion Bodies: a New Functional and Biocompatible Nanomaterial
    Dr. Elena García-Fruitós,
    CIBER-BBN Bioingeniería, Biomateriales y Nanomedicina, Institute for Biotechnology and Biomedicine, Applied Microbiology, Autonomous University of Barcelona, Spain

    16:50-17:10

    Title: Molecular Functions Designed in Protein Nanocage Assemblies
    Dr. Takafumi Ueno, Associate Professor, Institute for Integrated Cell-Material Sciences, Kyoto University, Japan

    17:10-17:30

    Panel Discussion


    Symposium 10: Protein Analysis and Quality Control

    Session 10-1: Progress of Analytical Techniques for Protein
    Time: March 22, 2010 13:30-15:30

    Chair

    Dr. Xueying Huang, President, Sepax Technologies, Inc., USA

    Co-Chair

    Dr. Rutao Liu, Professor, Deputy Dean, School of Environmental Sceince & Engineering, Shandong University, China

    13:30-13:55

    Title: New Packing Materials for High Resolution of Monoclonal Antibodies
    Dr. Xueying Huang, President, Sepax Technologies, Inc., USA

    13:55-14:20

    Title: High Sensitivity LabChip? Applications for Quality Control and Characterization of Monoclonal Antibodies and Other Proteins
    Dr.
    Raj Singh, Director of Assay Development, R&D Department, Caliper Life Sciences, USA

    14:20-14:45

    Title: Analytical and Comparability Strategies for the Development and Evaluation of Follow-on Biologics
    Dr. George Wang, Senior Director, Genor Biopharma, Co. Ltd., China

    14:45-15:10

    Title: Proteomic Analysis of Membrane Proteins Expressed Specifically in Pluripotent Murine Embryonic Stem Cells
    Dr.
    Akira Kurisaki, Senior Researcher, National Institute of Advanced Industrial Science and Technology, Japan

    15:10-15:30

    Coffee Break

    Session 10-2: Chip and Array Technology for Protein Analysis
    Time: March 22, 2010 15:30-17:30

    Chair

    Dr. Xueying Huang, President, Sepax Technologies, Inc., USA

    Co-Chair

    Dr. Rutao Liu, Professor, Deputy Dean, School of Environmental Sceince & Engineering, Shandong University, China

    15:30-15:55

    Title: Traceless and Site-Specific Immobilization of Proteins onto Solid Supports using Proteinf Trans-splicing
    Dr. Julio A. Camarero, Associate Professor, Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, USA

    15:55-16:20

    Title: Microcantilever Based Protein Quantification with Different Linkers and Receptors
    Dr. Sang Kyung Kim, Korea Institute of Science and Technology, Korea

    16:20-16:45

    Title: Microchip Capillary Electrophoresis Electrospray Ionization Mass Spectrometry for Rapid Characterization of Recombinant Human Erythropoietin
    Dr. Tiina Marjukka Sikanen, University of Helsinki, Finland

    16:45-17:10

    Title: Proteomic Analysis of Aminoglycoside Resistance in Mycobacteria
    Dr. Deepa Bisht, Scientist-C, Deptt. of Biochemistry, NJIL&OMD (ICMR), India

    17:10 -17:30

    Panel Discussion

    Session 10-3: HPLC, LC-MS and SFC in Protein Analysis
    Time: March 23, 2010 08:30-10:30

    Session Chair

    Dr. Liyu Yang, Associate Director, Bioanalytical Sciences, Drug Metabolism and Pharmacokinetics, Biogen Idec, Inc, USA

    Co-Chair

    Dr. Patrick J. Rudewicz, Director, Metabolism and Bioanalytical, Drug Metabolism and Pharmacokinetics, Elan Pharmaceuticals, Inc, USA

    08:30-08:50

    Keynote Speaker:
    Title: Characterization of Monoclonal Antibodies and Components Using Ultra-Performance Liquid Chromatography (UPLC) Technology
    Dr. Dorothy J. Phillips, Director, Waters Corporation, USA

    08:50-09:10

    Title: Quantitative and Qualitative LC/MS Methods for Peptides and Antibody-Drug Conjugates
    Dr. Liyu Yang, Associate Director, Bioanalytical Sciences, Drug Metabolism and Pharmacokinetics, Biogen Idec, Inc, USA

    09:10-09:30

    Title: The Study of Peptide Drug Metabolism Using Mass Spectrometry
    Dr. Patrick J. Rudewicz, Director, Metabolism and Bioanalytical, Drug Metabolism and Pharmacokinetics, Elan Pharmaceuticals, Inc, USA

    09:30-09:50

    Title: Technology to Enhance Quantitative Analysis in Complex Samples
    Dr. Xu Guo, Application Scientist, Product Application Laboratory, AB SCIEX, Canada

    09: 50-10:10

    Title: Advanced Cellulose Base Strong Ion Exchange Chromatography Media
    Dr. Masami Todokoro, Manager, Fine Chemicals Department, Chisso Corporation, Japan

    10:10-10:30

    Coffee Break

    Session 10-4: Spectroscopic Analysis and other GMP Compliance Analytical Methods
    Time: March 23, 2010 10:30-12:10

    Chair

    Dr. Liyu Yang, Associate Director, Bioanalytical Sciences, Drug Metabolism and Pharmacokinetics, Biogen Idec, Inc, USA

    Co-Chair

    Dr. Patrick J. Rudewicz, Director, Metabolism and Bioanalytical, Drug Metabolism and Pharmacokinetics, Elan Pharmaceuticals, Inc, USA

    10:30-10:50

    Title: Elucidation of Protein Oxidation by ESR, NMR and FT-Raman Spectroscopy
    Dr. Nazlin Howell, Professor, University of Surrey, UK

    10:50-11:10

    Title: Quantifying Protein Aggregation
    Dr. Hui Ning, Product Specialist, Nanometrics, Malvern Instruments China, China

    11:10-11:30

    Title: Vibrational Spectroscopy for Molecular Characterization of Proteins in the Diseased Skin of Dermatological Patients
    Dr. Natalja Skrebova Eikje, Director, MC Professional Oü, Estonia

    11:30-11:50

    Title: Spectroscopic Studies of Changes in Plasma Lipoproteins Induced by External Factors
    Dr. Dubravka Krilov, Associate Professor of Physics, University of Zagreb, Croatia

    11:50-12:10

    Title: High Sensitivity Aggregate Detection in Antibody Formulations
    Dr. Kevin Mattison, Senior Bioanalytical Scientist, Malvern Instruments Inc., USA

    Symposium 11: Protein Process Development and Manufacturing

    Session 11-1: Cell Line Engineering and Development
    Time: March 21, 2010 13:30-17:30

    Session Chair:

    Dr. Jianguo Yang, Principal Scientist and Group Leader, Genzyme, USA

    Co-Chair:

    Dr Thomas Jostock, Principal Scientist, Novartis, Switzerland

    13:30-13:50

    Keynote Speaker:
    Title:
    Challenges in Production Cell Line Development
    Dr. Jianguo Yang, Principal Scientist and Group Leader, Genzyme, USA

    13:50-14:10

    Title: Efficient Screening for Highest Producing Mammalian Cell Clones
    Dr. Christopher J. Mann, Senior Application Support Specialist, Genetix Inc., UK

    14:10-14:30

    Title: Next Generation of CHO-DHFR Selection System to Rapidly Create High-producing Stable Cell Line without MTX Amplification
    Dr. Xiaoyun Wu, CEO, ADV Bioscience LLC, USA

    14:30-14:50

    Title: High-throughput Expression Platform for Recombinant Human Antibody Cell Line Generation
    Dr. Cheng Liu, CEO & President, Eureka Therapeutics Inc., USA

    14:50-15:10

    Title: Accelerating CHO Cell Line Development by Implementing New Technologies
    Dr. Thomas Jostock, Principal Scientist, Novartis, Switzerland

    15:10-15:30

    Coffee Break

    15:30-15:50

    Title:Transient Expression as a Diagnostic Tool for Identification of Potentially Problematic Attributes before Stable Cell Line Development
    Dr. Janet Cheng, Principal Scientist, Amgen, USA

    15:50-16:10

    Title: Creation of High-Producer Host Cell Lines for Antibody Production Using Disparity Mutagenesis Technology
    Dr. Kaori Mine,
    Director of Global Business Development, Neo-Morgan Laboratory Inc., Japan

    16:10-16:30

    Title: Designing Automated Systems for Accelerating Cell Line Development.
    Dr. Robert Lund, Group Manager, Beckman Coulter Inc, USA

    16:30-16:50

    Title: Scaffold-free Cartilage Tissue Model Cultured Under Mechanical Stress Loading
    Dr. Katsuko S Furukawa, Associate Professor, University of Tokyo, Japan

    16:50-17:10

    TitleThe Industrialisation of Soybean Bioactive Peptides Microbial Fermentation Program
    Mr. Mingxue Sun, the Vice Chairman and the Director, Xi’an Guocui Peptide Biology Co. Ltd., China

    17:10-17:30

    Panel Discussion

    Session 11-2: Improved Separation, Purification, Recovery, Crystallization, and Lyophilization
    Time: March 22, 2010 08:30-10:55

    Session Chair:

    Dr. Henry C Chiou, Principal Scientist, Life Technologies, USA

    08:30-08:50

    Keynote Speaker:
    Title: Downstream Processing 2.0: From a Bottleneck to a Pacemaker
    Dr. Yujing Yang, Director, Purification Technologies North America, USA

    08:50-09:10

    Title: Introduction and Application of Bioseparation Media, TOYOPEARL for Separation of Monoclonal Antibody
    Dr. Oscar Yamasaki, General Manager, Sales & Marketing Dept. Tosoh co., Inc., Japan

    09:10-09:30

    Title: Efficient and Flexible Process for Recombinant Therapeutic Protein Production
    Dr. Michelle Xia, Vice President, Crown Bioscience Inc., USA

    09:30-09:50

    Title: A New Strategy for Purification of Intact Proteins Simultaneously Satisfying with High Resolution, High Speed, High Sample Loading
    Dr. Xindu Geng, Full Professor, Director of Institute of Modern Separation Science, Northwest University, China

    09:50-10:10

    Title: A Multi-Mode Interaction Theory for Predicting Protein Elution Profiles in Isoelectric Chromatofocusing
    Dr. Derek Yau Chung Choy, Michael Smith Laboratories, Canada

    10:10-10:30

    Title: A Novel Recombinant System for Efficient Expression of Unstable Proteins--Using a New Fusion Affinity Tag and High-performance Cleavage Enzyme
    Dr. Tomohisa Ogawa, Associate Professor, Tohoku University, Japan

    10:30-10:50

    Title: Arginine as a Versatile Reagent for Handling Proteins
    Dr. Kouhei Tsumoto, Associate Professor, The University of Tokyo, Japan

    10:50-10:55

    Coffee Break

    Session 11-3: Scaling Up Bioprocess Development for Biotherapeutics
    Time: March 22, 2010 10:55-12:15

    Session Chair:

    Dr. Henry C Chiou, Principal Scientist, Life Technologies, USA

    Co-Chair:

    Dr. Xiaojian(David) Zhao, Director, Research and Development, EMD Chemicals Inc., USA

    10:55-11:15

    Title: Novel Approach to Chemically Defined Platform Medium and Feed Development for CHO Cell Culture
    Dr.
    Xiaojian(David) Zhao, Director, Research and Development, EMD Chemicals Inc., USA

    11:15-11:35

    Title: Key Considerations in Upscaling Transient Bioproduction in HEK293 and CHO Cells and Alignment with Stable Cell Line Development
    Dr. Henry C Chiou, Principal Scientist, Life Technologies, USA

    11:35-11:55

    Title: PURE System for Production of Target Protein and Antibody Drugs
    Dr. Takuya Ueda, Professor, The University of Tokyo, Japan

    11:55-12:15

    Title: Optimization and Validation of Virus Filtration Process
    Dr. In Seop Kim, Associate Professor, Department of Biological Sciences, Hannam University, South Korea

    Session 11-4: Cell Culture and Up- Stream Process Development
    Time: March 22, 2010 13:30-15:30

    Session Chair:

    Dr. Xiao Ping Dai, Assistant Director, Medarex Inc., USA

    13:30-13:50

    Title: On-Line Monitoring: Animal Cell Cultivation in Suspension and Fixed-Bed Bioreactor Using Dielectric Measurements and Spectroscopy Scanning
    Dr. Olivier Berteau, Director, Fogale Nanotech, France

    13:50-14:10

    Title: Platform Strategy for Upstream Process Development - Streamlining Efficiency, Product Quality, Technology Transfer and Scale Up
    Dr. Xiao Ping Dai,
    Assistant Director, Medarex Inc., USA

    14:10-14:30

    Title: Development and Implementation of Harmonized Cell Culture Process for Therapeutic Monoclonal Antibodies
    Dr. Jun Luo, Sr. Engineer, Genetech Inc., USA

    14:30-14:50

    Title: Contracting for Biopharmaceutical Process Development
    Dr. William G. Whitford, Sr. Manager, BioProcessing Market, Thermo Fisher Scientific, USA

    14:50-15:10

    Title: Human Blood Dendritic Cell Preparation, Culture, and Immunological Assay
    Dr. Jong-Young Kwak, Professor/Director, Dong-A University, South Korea

    15:10-15:30

    Coffee Break

    Session 11-5: New Protein Therapeutic Formulation Development
    Time: March 22, 2010 15:30-17:30

    Session Chair:

    Dr. Xiao Ping Dai, Assistant Director, Medarex Inc., USA

    15:30-15:50

    Keynote Speaker
    Title: Studies of Protein Aggregation and Particulates in Support of GMP Manufacturing
    Dr. Li Shi,
    Senior Director, Genzyme, USA
    Presenter: Dr. Yang Jianguo

    15:50-16:10

    Title: Functional Proteins and Peptides in Human Milk and Pediatric Nutrition
    Dr. Eduard K. Poels, Vice President, Mead Johnson Nutrition, USA

    16:10-16:30

    Title: Sustained Delivery of Proteins and Peptides: Experience with Mutivesicular Liposomes
    Dr. William J. Lambert, Senior Vice President, Pharmaceutical Development, Pacira Pharmaceuticals, Inc.,USA

    16:30-16:50

    Title: Monitoring and Predicting Protein Formulation Stability Using Non-Invasive Light Scattering Techniques
    Dr. Kevin Mattison, Senior Bioanalytical Scientist, Malvern Instruments Inc., USA

    16:50-17:10

    Title: Furin as an Established Endoproteolytic Proprotein Processing Tool for Enhanced Manufacturing of Recombinant Biopharmaceutical Proteins.
    Dr. Willem Van de Ven, Professor, University of Leuven, Belgium

    17:10-17:30

    Panel Discussion

    Symposium 12: Proteins as Drugs-Non-Antibody and Non-Vaccine Protein Therapeutics

    Session 12- 1: Proteins as Drugs-Non-Antibody and Non-Vaccine Protein Therapeutics
    Time: March 23, 2010 08:30-12:10

    Session Chair

    Dr. Nathalie Grandvaux, Canada Research Chair in Signaling and Virus Infections, Dept of Biochemistry and CHUM Research Center , University of Montreal, Canada

    Co-Chair

    Dr. Wei-Chiang Shen, Professor in Pharmaceutical Sciences, University of Southern California, USA

    08:30-08:50

    Keynote Speaker:
    Title: Recombinant Granulocyte Colony-Stimulating Factor and Transferrin Fusion Proteins as Myelopoietic Agents
    Dr. Wei-Chiang Shen, Professor in Pharmaceutical Sciences, University of Southern California, USA

    08:50-09:10

    Title: Designing Automated Sample Preparation Systems for Flow Cytometry Analysis
    Dr. Robert Lund, Group Manager, Beckman Coulter, USA

    09:10-09:30

    Title: New Insight into the Redox Regulation of Proinflammatory and Antiviral Cytokines Production in RNA Virus Infections
    Dr. Nathalie Grandvaux, Canada Research Chair in signaling and virus infections, Dept. of Biochemistry and CHUM Research center, University of Montreal, Canada

    09:30-09:50

    Title: Molecular Mechanism of Growth Hormone Regulation of Insulin-like Growth Factor 1 Gene Expression
    Dr. Honglin Jiang, Associate Professor, Animal and Poultry Sciences, Virginia Polytechnic Institute and State University, USA

    09:50-10:10

    Title: Molecular Mechanisms of Insulin and IGF Receptor Binding
    Dr. Briony Forbes, Senior Research Fellow, Molecular and Biomedical Sciences, The University of Adelaide, AUSTRALIA

    10:10-10:30

    Coffee Break

    10:30-10:50

    Title: The Role of ZNF521 Protein in Hematopoietic Cells
    Dr. Ikuya Sakai, Professor, College of Pharmaceutical Sciences, School of Clinical Pharmacy, Matsuyama University, Japan

    10:50-11:10

    Title: How Do We Increase Insulin-like Growth Factor-I Production? ; the Molecular Mechanism and Possible Therapeutic Usefulness
    Dr. Kenji Okajima, Professor, Department of Translational Medical Science Research, Nagoya City University, Japan

    11:10-11:30

    Title: The Effects of Granulocyte Colony-Stimulating Factor (G-CSF) on Cardiac Mitochondria
    Dr. Eri Iwai-Kanai, Associate Professor, Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto Prefectural University of Medicine, Japan

    11:30-12:10

    Panel Discussion

    Workshop : Biotechnology and Technology Transfer
    Time: March 23, 2010 13:30-14:15

    Session Chair

    Mr. John P. Iwanicki, Esq., Principal Shareholder, Banner & Witcoff, Ltd., USA

    13:30-14:15

    Title: Patents: The Sword and the Shield in a Highly Competitive Market
    Mr. John P. Iwanicki, Esq., Principal Shareholder, Banner & Witcoff, Ltd., USA

    Young Scientists Forum
    Time: March 23, 2010 14:20-17:30
    Place:
    311C, 3F,BICC

    Session Chair

    Hsin-hao Timothy Hsiao, PhD candidate in Molecular Biophysics & Biochemistry, Yale University, USA

    14:20-14:45

    Title: Reproducibility Assessement and Statistical Quantification in Mass Spec Data from Clinical Proteomics Study
    Irene Zeng, PhD Student ,Faculty of Science, The University of Auckland, Newzealand

    14:45-15:10

    Title: Tumor Repressive Function of Estrogen Receptor in Malignant Pleural Mesothelioma
    Giulia Pinton,
    PhD Student, (DiSCAFF), University of Piemonte Orientale “Amedeo Avogadro”, Italy

    15:10-15:30

    Coffee Break

    15:30-15:55

    Title: At the Interface: Comparative Analysis Reveals the Structural Basis for FIR/PUF60 to Navigate between Transcriptional Regulation and pre-mRNA Splicing
    Hsin-hao Timothy Hsiao,
    PhD candidate in Molecular Biophysics & Biochemistry, Yale University, USA

    15:55-16:20

    Title: Primitive Metalloenzymes Inspired by Nature
    Dr. Marc Creus, Postdoctoral Scientific Collaborator and HABILITAND (Group Leader), Department of Chemistry, University of Basel, Switzerland

    16:20-16:45

    Title: Cell-penetrating Peptides (CPPs) Facilitate the Uptake of Bioactive Cargo into Cells and Induce its Effective Leakage from the Vesicles to the Cytosol
    Helin Räägel, Estonian Biocentre, Estonia

    16:45-17:10

    Title: How arginine as an excipient affects the stability of concentrated protein formulations?
    Dr. Dhawal Shah, National University of Singapore, Singapore

    17:10-17:30

    Panel Discussion


    © 2008-2010 All right reserved for BIT Conferences
    Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84799629